<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81943</article-id><article-id pub-id-type="doi">10.7554/eLife.81943</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-286448"><name><surname>Szego</surname><given-names>Eva M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2629-2131</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-286449"><name><surname>Malz</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-286450"><name><surname>Bernhardt</surname><given-names>Nadine</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3188-8431</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-297465"><name><surname>Rösen-Wolff</surname><given-names>Angela</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9613-5879</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-286452"><name><surname>Falkenburger</surname><given-names>Björn H</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2387-526X</contrib-id><email>Bjoern.Falkenburger@dzne.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-286453"><name><surname>Luksch</surname><given-names>Hella</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7070-4992</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/042aqky30</institution-id><institution>Department of Neurology, TU Dresden</institution></institution-wrap><addr-line><named-content content-type="city">Dresden</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/042aqky30</institution-id><institution>Departments of Neurology &amp; Pediatrics, TU Dresden</institution></institution-wrap><addr-line><named-content content-type="city">Dresden</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/042aqky30</institution-id><institution>Department of Psychiatry, TU Dresden</institution></institution-wrap><addr-line><named-content content-type="city">Dresden</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/042aqky30</institution-id><institution>Department of Pediatrics, TU Dresden</institution></institution-wrap><addr-line><named-content content-type="city">Dresden</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043j0f473</institution-id><institution>Deutsches Zentrum für Neurodegenerative Erkrankungen</institution></institution-wrap><addr-line><named-content content-type="city">Dresden</named-content></addr-line><country>Germany</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/042aqky30</institution-id><institution>Department of Pediatrics, TU Dresden</institution></institution-wrap><addr-line><named-content content-type="city">Dresden</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ye</surname><given-names>Keqiang</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/034t30j35</institution-id><institution>Chinese Academy of Sciences</institution></institution-wrap><country>China</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>31</day><month>10</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e81943</elocation-id><history><date date-type="received" iso-8601-date="2022-08-02"><day>02</day><month>08</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-10-31"><day>31</day><month>10</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-02-04"><day>04</day><month>02</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.02.02.478854"/></event></pub-history><permissions><copyright-statement>© 2022, Szego, Malz et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Szego, Malz et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81943-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-81943-figures-v2.pdf"/><abstract><p>Stimulator of interferon genes (STING) is activated after detection of cytoplasmic dsDNA by cGAS (cyclic GMP-AMP synthase) as part of the innate immunity defence against viral pathogens. STING binds TANK-binding kinase 1 (TBK1). TBK1 mutations are associated with familial amyotrophic lateral sclerosis, and the STING pathway has been implicated in the pathogenesis of further neurodegenerative diseases. To test whether STING activation is sufficient to induce neurodegeneration, we analysed a mouse model that expresses the constitutively active STING variant N153S. In this model, we focused on dopaminergic neurons, which are particularly sensitive to stress and represent a circumscribed population that can be precisely quantified. In adult mice expressing N153S STING, the number of dopaminergic neurons was smaller than in controls, as was the density of dopaminergic axon terminals and the concentration of dopamine in the striatum. We also observed alpha-synuclein pathology and a lower density of synaptic puncta. Neuroinflammation was quantified by staining astroglia and microglia, by measuring mRNAs, proteins and nuclear translocation of transcription factors. These neuroinflammatory markers were already elevated in juvenile mice although at this age the number of dopaminergic neurons was still unaffected, thus preceding the degeneration of dopaminergic neurons. More neuroinflammatory markers were blunted in mice deficient for inflammasomes than in mice deficient for signalling by type I interferons. Neurodegeneration, however, was blunted in both mice. Collectively, these findings demonstrate that chronic activation of the STING pathway is sufficient to cause degeneration of dopaminergic neurons. Targeting the STING pathway could therefore be beneficial in Parkinson’s disease and further neurodegenerative diseases.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>Neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases are characterised by neurons getting damaged and dying. Many factors contribute to this process, but few can be effectively controlled by therapies. Interestingly, previous studies have highlighted that inflammation, a process normally triggered by foreign agents or biological damage, is often associated with neurons degenerating. However, it is unclear whether these responses are the cause or the consequence of brain cell damage.</p><p>In injured neurons, the genetic information normally contained inside a dedicated cellular compartment can start to leak into the surrounding parts of the cell. This damage triggers an inflammatory response through the STING pathway, a mechanism previously implicated in the onset of Parkinson’s disease. In these patients, the neurons that produce the signalling molecule dopamine start to die, leading to difficulty with movement. Whether STING can directly cause this neuronal loss remains unknown.</p><p>To answer this question, Szegö, Malz et al. genetically engineered mice in which the STING pathway is permanently activated. The animals had fewer dopamine-producing neurons and accumulated harmful clumps of proteins; both these biological features are characteristic signs of Parkinson’s disease. Crucially, signs of inflammation were present before neurons started to show damage, suggesting that inflammatory responses could cause neurodegeneration. Further experiments revealed that STING triggers several molecular cascades; blocking one only of these pathways did not keep the neurons healthy.</p><p>Neurodegenerative diseases are a growing concern around the world. The results from Szegö, Malz et al. suggest that preventing prolonged inflammatory may reduce the risk of neurodegeneration. If further research confirms these findings, in particular in humans, well-known treatments against inflammation could potentially become relevant to fight these conditions.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>parkinson</kwd><kwd>synuclein</kwd><kwd>neurodegeneration</kwd><kwd>innate immunity</kwd><kwd>neuroinflammation</kwd><kwd>inflammasome</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>FA-658-3-1</award-id><principal-award-recipient><name><surname>Falkenburger</surname><given-names>Björn H</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB TRR237, B18</award-id><principal-award-recipient><name><surname>Rösen-Wolff</surname><given-names>Angela</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Constitutive activation of an innate immunity response in mouse brain causes degeneration of dopaminergic neurons, suggesting novel targets for potentially neuroprotective strategies.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Inflammation is recognized increasingly as a major driver for neurodegenerative diseases, including Parkinson’s disease (PD) (<xref ref-type="bibr" rid="bib28">Harms et al., 2021</xref>; <xref ref-type="bibr" rid="bib31">Hirsch and Standaert, 2021</xref>). The stimulator of interferon genes (STING) responds to cytoplasmic dsDNA as part of the innate immunity defence against viral pathogens (<xref ref-type="bibr" rid="bib57">Paul et al., 2021</xref>). STING is activated by cyclic GMP-AMP (cGAMP) produced by cGAMP synthase (cGAS) upon binding to dsDNA (<xref ref-type="bibr" rid="bib49">Motwani et al., 2019</xref>). This pathway can be activated by pathogen-derived nucleic acids but also by cytoplasmic self-DNA (<xref ref-type="bibr" rid="bib10">Chen et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Li and Chen, 2018</xref>; <xref ref-type="bibr" rid="bib49">Motwani et al., 2019</xref>). STING binds TANK-binding kinase 1 (TBK1) and activates the transcription factors interferon regulatory factor 3 (IRF3) (<xref ref-type="bibr" rid="bib11">Chen et al., 2021</xref>) and nuclear factor 'kappa-light-chain-enhancer' of activated B-cells (NF-κB) (<xref ref-type="bibr" rid="bib42">Liu et al., 2014</xref>). The resulting increased production of type I interferons (IFN) and pro-inflammatory cytokines induce the activation of inflammasomes and inflammation (<xref ref-type="bibr" rid="bib33">Hopfner and Hornung, 2020</xref>). STING, however, can activate inflammasomes directly (<xref ref-type="bibr" rid="bib76">Wang et al., 2020</xref>). Inflammasomes are major signalling hubs that activate caspase-1 and control the bioactivity of pro-inflammatory cytokines of the interleukin (IL)–1 family (<xref ref-type="bibr" rid="bib23">Gaidt et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Schroder and Tschopp, 2010</xref>).</p><p>The cGAS-STING pathway has been implicated in PD pathogenesis. Mice deficient for the PD-associated proteins PTEN-induced kinase 1 (PINK) and parkin show a STING-mediated inflammatory phenotype after exhaustive exercise (<xref ref-type="bibr" rid="bib68">Sliter et al., 2018</xref>). This phenotype results from the PINK/parkin-dependent failure to degrade damaged mitochondria and the consecutive accumulation of mitochondrial DNA in the cytosol. Indeed, inflammatory markers like IL-6 were also observed in human patients with parkin mutations (<xref ref-type="bibr" rid="bib68">Sliter et al., 2018</xref>). Similarly, cytoplasmic accumulation of TDP-43, which constitutes the most common pathological finding in sporadic amyotrophic lateral sclerosis (ALS), triggers the release of mitochondrial DNA and the consecutive, STING-dependent neuroinflammation and neurodegeneration (<xref ref-type="bibr" rid="bib83">Yu et al., 2020</xref>). In addition, mutations in TBK1 are associated with familial ALS (<xref ref-type="bibr" rid="bib19">Freischmidt et al., 2015</xref>). Finally, activation of inflammasomes formed by the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) has been linked to the progression of several neurodegenerative diseases (<xref ref-type="bibr" rid="bib29">Heneka et al., 2018</xref>).</p><p>Neuroinflammation receives growing attention in neurodegenerative diseases because it represents a promising therapeutic target. Designing such therapies, however, requires to determine the specific effects of individual components of this highly interconnected signalling network, which responds to diverse stimuli and involves many different cell types. Previous studies have demonstrated that depleting or blocking STING can alleviate neurodegeneration in models of PD (<xref ref-type="bibr" rid="bib68">Sliter et al., 2018</xref>) and ALS (<xref ref-type="bibr" rid="bib83">Yu et al., 2020</xref>). To complement these observations and provide a model to study the signalling downstream of STING, we wanted to determine whether specific activation of STING is sufficient to cause neurodegeneration. In order to test this, we used a mouse model with heterozygous expression of the STING genetic variant N153S (<xref ref-type="bibr" rid="bib45">Luksch et al., 2019</xref>). Constitutively active STING mutants cause an autoinflammatory disease in humans termed STING-associated vasculopathy with onset in infancy (SAVI) (<xref ref-type="bibr" rid="bib13">Crow and Casanova, 2014</xref>; <xref ref-type="bibr" rid="bib42">Liu et al., 2014</xref>). SAVI is characterized by systemic inflammation with acral vasculitis, T cell lymphopenia, and interstitial pulmonary disease. Major features of systemic inflammation in SAVI are recapitulated in STING N153S knock-in mice (<xref ref-type="bibr" rid="bib45">Luksch et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Siedel et al., 2020</xref>). For simplicity, we refer to these as STING ki mice here and use the term STING WT for the corresponding wild type littermate controls. In these mice, we determined the extent of neuroinflammation and quantified the integrity of dopaminergic neurons that project from the substantia nigra pars compacta to the striatum. We focused on dopaminergic neurons because they have been the centre of our investigations (<xref ref-type="bibr" rid="bib18">Falkenburger et al., 2001</xref>; <xref ref-type="bibr" rid="bib37">Komnig et al., 2018</xref>; <xref ref-type="bibr" rid="bib74">Szegö et al., 2022</xref>; <xref ref-type="bibr" rid="bib70">Szego et al., 2012</xref>), and because STING has been implicated in the pathogenesis of PD (<xref ref-type="bibr" rid="bib30">Hinkle et al., 2022</xref>; <xref ref-type="bibr" rid="bib68">Sliter et al., 2018</xref>). Furthermore, we measured alpha-synuclein (aSyn) pathology, which constitutes the second neuropathological feature of PD next to the degeneration of dopaminergic neurons. To determine which of the known downstream signalling pathways contribute to STING-induced neurodegeneration, we used mice deficient for type I IFN receptor (<italic>Ifnar1</italic>) or caspase 1 (<italic>Casp1</italic>).</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Neuroinflammation and degeneration of dopaminergic neurons in mice with constitutive STING activation</title><p>To characterize the neuronal phenotype in adult STING ki mice, we assessed neuroinflammation and the integrity of the dopaminergic nigrostriatal system. First, we stained striatal sections for Iba1 to determine the activation of microglia. The Iba1 positive area fraction was 9-fold higher in STING ki mice than in STING WT (<xref ref-type="fig" rid="fig1">Figure 1A and C</xref>), accompanied by an 3.8-fold increase in the number of Iba1-positive cells (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Activation of astroglia, as determined by GFAP staining, was 26-fold higher in STING ki mice than in STING WT (<xref ref-type="fig" rid="fig1">Figure 1B and D</xref>), and the number of astroglial cells increased to 6.7-fold (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Similarly, in the substantia nigra (SN), activation of astroglia (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C, F, H</xref>) and microglia (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C, G, I</xref>) increased as well. Thus, STING ki mice exhibit a strong neuroinflammatory phenotype, consistent with increased systemic inflammation (<xref ref-type="bibr" rid="bib45">Luksch et al., 2019</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Constitutive STING activation induces neuroinflammation and neurodegeneration in adult mice.</title><p>(<bold>A</bold>) Representative images of striatal sections from STING WT and STING ki mice stained for the microglia marker Iba1. Scale bar: 50 μm. (<bold>B</bold>) Representative images of striatal sections stained for the astroglia marker GFAP. Scale bar: 50 μm. (<bold>C</bold>) Representative images of midbrain sections containing the substantia nigra (SN) from STING WT and STING ki mice (stitched from two microscopy fields) stained for tyrosine hydroxylase (TH). Scale bar: 100 μm. (<bold>D</bold>) Representative images of striatal sections stained for TH from STING WT and STING ki mice. Scale bar: 10 μm. (<bold>E</bold>) Area fraction positive for Iba1, normalized to the mean of STING WT mice. Markers represent individual animals (black: STING WT animals, red: STING ki animals). Lines represent mean ± SD. Comparison by t-test (***: p=0.0007, n=5). Graph showing the counted numbers of Iba1-positive neurons is on <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>. (<bold>F</bold>) Area fraction positive for GFAP, normalized to the mean of STING WT mice (**: p=0.0011; t-test, n=5). Graph showing the counted numbers of GFAP-positive neurons is on <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>. (<bold>G</bold>) Number of TH-positive neurons (*: p=0.0257; t-test, n=5). Graph showing the counted numbers of dopaminergic neurons is on <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>. (<bold>H</bold>) Area fraction positive for TH (**: p=0.0081; t-test, n=5). (<bold>I</bold>) Concentration of dopamine (*: p=0.0448; t-test, n=5) in striatal lysates from STING WT and STING ki animals, normalized to the mean concentration in STING WT. Graph showing quantification of the dopamine metabolites is in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Neuroinflammation and neurodegeneration in adult mice.</title><p>(<bold>A</bold>) Number of Iba1-positive microglia in the striatum of adult mice (<italic>P</italic>=0,0000, t-test). (<bold>B</bold>) Number of GFAP-positive astroglia in the striatum of adult mice (p=0.0029, t-test). (<bold>C</bold>) Representative images on the ventral midbrain containing the substantia nigra of STING WT and STING ki mice, stained for TH (cyan), Iba1 (magenta) and GFAP (green). Scale bar: 100 µm. Insets show grayscale signal of Iba1 or GFAP staining. (<bold>D</bold>) Number of TH-positive neurons in the substantia nigra of adult mice (p=0.0257; t-test). (<bold>E</bold>) Dopamine metabolism (concentration of dopamine metabolites DOPAC +HVA) / dopamine in adult mice (p=0.0179; t-test). (<bold>F</bold>) Area fraction positive for GFAP signal in the substantia nigra as relative to the mean of STING WT (**: p=0.0078; t-test). (<bold>G</bold>) Area fraction positive for Iba1 signal in the substantia nigra as relative to the mean of STING WT (**: p=0.0078; t-test). (<bold>H</bold>) Number of counted GFAP-positive cells in the substantia nigra of adult mice (p=0.0003, t-test). (<bold>I</bold>) Number of counted Iba1-positive cells in the substantia nigra of adult mice (p=0.0000, t-test). n=5 for all graphs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig1-figsupp1-v2.tif"/></fig></fig-group><p>Next, we asked whether the chronic neuroinflammation in the STING ki mice is associated with the degeneration of dopaminergic neurons. Somata of dopaminergic neurons in the SN (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) and dopaminergic axon terminals in the striatum (<xref ref-type="fig" rid="fig1">Figure 1F</xref>) were identified by staining for tyrosine hydroxylase (TH). The SN of STING ki mice contained significantly fewer TH-positive neurons than the SN of STING WT (<xref ref-type="fig" rid="fig1">Figure 1G</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Similarly, the density of dopaminergic axon terminals (fibers) in the striatum was lower in STING ki mice than in STING WT (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). Accordingly, the concentration of dopamine in the striatum was lower in STING ki mice than in STING WT mice (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). The concentration of dopamine metabolites was higher in STING ki mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>), suggesting increased dopamine turnover in STING ki mice - as commonly observed with degeneration of dopaminergic axon terminals. Taken together, these findings demonstrate that the integrity of nigrostriatal dopaminergic neurons is compromised in STING ki mice.</p></sec><sec id="s2-2"><title>Neuroinflammation without degeneration of the dopaminergic neurons in juvenile mice with constitutive STING activation</title><p>In order to explore whether the compromised integrity of dopaminergic neurons is a consequence of a prolonged neuroinflammation, we next analysed brain sections of juvenile (5-week-old) STING ki and STING WT mice (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Microglia was already significantly activated in juvenile STING ki mice. The area fraction of the Iba1 staining was twofold higher in STING ki mice than in STING WT (<xref ref-type="fig" rid="fig2">Figure 2A and E</xref>). Similarly, the area fraction of GFAP signal was 14-fold higher in STING ki mice than in STING WT (<xref ref-type="fig" rid="fig2">Figure 2B and F</xref>), suggesting activation of astroglia in juvenile STING ki mice. However, the number of TH-positive neurons in the substantia nigra was not different between juvenile STING ki mice and STING WT (<xref ref-type="fig" rid="fig2">Figure 2C and G</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Similarly, striatal axon terminals (<xref ref-type="fig" rid="fig2">Figure 2D and H</xref>) and the concentrations of striatal dopamine and its metabolites (<xref ref-type="fig" rid="fig2">Figure 2I</xref>, and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>) were not different between STING ki mice and STING WT.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Neuroinflammation without neurodegeneration in juvenile mice with constitutive STING activation.</title><p>(<bold>A</bold>) Representative images of striatal sections stained for the microglia marker Iba1 from 5-week-old STING WT and STING ki mice. Scale bar: 50 μm (<bold>B</bold>) Representative images of striatal sections stained for the astroglia marker GFAP from 5-week-old STING WT and STING ki mice. Scale bar: 50 μm (<bold>C</bold>) Representative images of midbrain sections containing the substantia nigra (SN, stitched from two microscopy fields) stained for tyrosine hydroxylase (TH) from 5-week-old STING WT and STING ki mice. Scale bar: 100 μm (<bold>D</bold>) Representative images of striatal sections stained for TH from 5-week-old STING WT and STING ki mice. Scale bar: 10 μm. (<bold>E</bold>) Area fraction positive for Iba1, normalized to the mean of STING WT (***: p=0,0009; t-test, n=5–6). (<bold>F</bold>) Area fraction positive for GFAP, normalized to the mean of STING WT brains (***: p=0.0007; t-test, n=5–6). (<bold>G</bold>) Number of TH-positive neurons (mean ± SD; t-test). Graph showing the counted numbers of dopaminergic neurons is on <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>. (<bold>H</bold>) Area fraction positive for TH (mean ± SD, t-test, n=5–6). (<bold>I</bold>) Dopamine concentration in striatal lysates from 5-week-old STING WT and STING ki mice, measured by HPLC and normalized to the mean of STING WT (mean ± SD, t-test, n=5–6). Dopamine metabolites are in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Neuroinflammation without neurodegeneration in juvenile mice.</title><p>(<bold>A</bold>) Number of TH-positive neurons in the substantia nigra of juvenile mice (p=0.5188; t-test). (<bold>B</bold>) Dopamine metabolism in juvenile mice (p=0.9545; t-test). n=5–6.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig2-figsupp1-v2.tif"/></fig></fig-group><p>Taken together, these findings demonstrate that the compromised integrity of the nigrostriatal system in adult STING ki mice (<xref ref-type="fig" rid="fig1">Figure 1</xref>) represents an adult-onset neurodegeneration and not a developmental defect. Given that activation of microglia and astroglia in STING ki mice precedes degeneration of dopaminergic neurons, STING-induced neuroinflammation could contribute to the neurodegeneration.</p></sec><sec id="s2-3"><title>aSyn pathology and synaptic defects in the striatum of STING ki mice</title><p>In PD, degeneration of dopaminergic neurons is associated with aSyn pathology. We therefore analysed aSyn pathology in the striatum and in the SN of STING ki mice. First, we measured the amount of aSyn protein phosphorylated at serine 129 (paSyn), which is considered one of the major pathological forms of aSyn (<xref ref-type="bibr" rid="bib1">Anderson et al., 2006</xref>; <xref ref-type="bibr" rid="bib22">Fujiwara et al., 2002</xref>; <xref ref-type="bibr" rid="bib64">Samuel et al., 2016</xref>). Both striatal and nigral lysates of adult STING ki mice contained a substantial amount of paSyn (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>), which was barely detectable in STING WT. The amount of total aSyn was lower in STING ki mice in both brain regions (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) and the ratio of paSyn to total aSyn increased in STING ki mice (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) – as commonly observed in synucleinopathy models and PD patients (<xref ref-type="bibr" rid="bib1">Anderson et al., 2006</xref>; <xref ref-type="bibr" rid="bib9">Chatterjee et al., 2020</xref>; <xref ref-type="bibr" rid="bib22">Fujiwara et al., 2002</xref>; <xref ref-type="bibr" rid="bib74">Szegö et al., 2022</xref>). To further characterize aSyn pathology in STING ki mice, we assayed the Triton X-100 solubility of αSyn in lysates prepared from the striatum or from the SN (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In lysates prepared from STING ki animals, αSyn was detected both in the Triton X-100 insoluble fraction (<xref ref-type="fig" rid="fig3">Figure 3C</xref> upper panel) and in the Triton X-100 soluble fraction (<xref ref-type="fig" rid="fig3">Figure 3C</xref> lower panel). In lysates prepared from STING WT animals, αSyn was barely detectable in the Triton X-100 insoluble fraction. Consequently, the ratio of insoluble to soluble aSyn was strongly increased in STING ki mice (<xref ref-type="fig" rid="fig3">Figure 3D</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Constitutive STING activation induces alpha-synuclein pathology and synapse loss in adult mice.</title><p>(<bold>A</bold>) Representative western blot images showing phosphorylated alpha-synuclein (S129; paSyn) and the loading control βIII-tubulin detected from the substantia nigra (upper panel) and striatum (lower panel). Total levels of aSyn detected from the same membranes are shown on <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A, B</xref>. (<bold>B</bold>) Ratio of paSyn and total aSyn signals, expressed as relative to the mean of STING WT (substantia nigra (SN): p=0.000065; striatum: p=0.019; t-test, n=5). (<bold>C</bold>) Representative western blot images showing aSyn and βIII-tubulin detected from the Triton X-100 insoluble (upper panel) and soluble (lower panel) fractions prepared from the substantia nigra or from the striatum. (<bold>D</bold>) Ratio of aSyn signals detected in the Triton X-100 soluble and insoluble fractions, expressed as relative to the mean of STING ki (substantia nigra (SN): p=0.00001; striatum: p&lt;0.00001; t-test, n=6). (<bold>E</bold>) Representative images of striatal sections from 20-week-old STING WT and STING ki mice stained with Thioflavin S (magenta) and nuclear sdye (blue) on the composite images, and ThioS BW. Scale bar: 20 μm. (<bold>F</bold>) Number of cells with inclusions positive for Thioflavin S (ThioS) per mm<sup>2</sup> (*: p=0.0141; t-test, n=5). (<bold>G</bold>) Representative images of striatal sections from 20-week-old STING WT and STING ki mice stained for the presynaptic marker synapsin (upper panel) or for the post-synaptic marker homer (lower panel). Scale bar: 10 μm. (<bold>H–I</bold>) Area fraction positive for synapsin (H, p=0.0053) or homer (I, p=0.0408) (mean ± SD; t-test, n=5).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Uncropped membranes showing α-Synuclein signal detected from whole cell lysates of striatum and substantia nigra.</title><p>(<bold>A</bold>) Representative Western blot membrane showing aSyn signal in lysates prepared from the substantia nigra of STING WT and STING ki mice. (<bold>B</bold>) Representative Western blot membrane showing aSyn signal in lysates prepared from the striatum of STING WT and STING ki mice. (<bold>C</bold>) Ratio of aSyn and βIII tubulin in lysates prepared from the substantia nigra (SN) or striatum, expressed as relative to the mean of STING WT (SN: *: p=0.0462; STR: *: p=0.0491, t-test, n=5).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Uncropped membranes showing α-Synuclein signal detected from whole cell lysates of striatum and substantia nigra.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-81943-fig3-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig3-figsupp1-v2.tif"/></fig></fig-group><p>As an alternative approach to detect aggregated proteins, we used Thioflavin S (ThioS), which binds to the characteristic β-sheet conformation of amyloid-containing proteins, including aSyn (<xref ref-type="bibr" rid="bib21">Froula et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Neumann et al., 2002</xref>). The number of cells with ThioS-positive inclusions was higher in the striatum of adult STING ki mice than in STING WT (<xref ref-type="fig" rid="fig3">Figure 3E and F</xref>), consistent with the findings from the aSyn immunoblots (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>).</p><p>Since dopamine depletion and aSyn pathology can compromise synaptic integrity, we next quantified the density of synapses in the striatum. Presynaptic puncta were detected by staining against synapsin; post-synaptic puncta were detected by staining against homer (<xref ref-type="fig" rid="fig3">Figure 3G–I</xref>). The density of synapsin puncta was 18% lower in adult STING ki than in STING WT (<xref ref-type="fig" rid="fig3">Figure 3H</xref>), the density of post-synaptic puncta was 9% lower in STING ki than in STING WT mice (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). In summary, we observed aSyn pathology in the striatum and in the SN, and a reduced density of synapses in the striatum of adult STING ki mice.</p></sec><sec id="s2-4"><title>Type I IFN signalling and NF-κB and inflammasome-dependent signalling are activated in the brain of STING ki mice</title><p>In order to analyse the signalling pathways by which constitutively active STING causes degradation of dopaminergic neurons and aSyn pathology, we examined the expression of selected interferon-stimulated genes (ISGs) by quantitative real time PCR in the SN and in the striatum of adult STING ki and STING WT mice (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Expression of the interferon-induced protein 44 (<italic>Ifi44</italic>, <xref ref-type="fig" rid="fig4">Figure 4A and G</xref>) and the interferon-induced GTP-binding protein <italic>Mx1</italic> (<xref ref-type="fig" rid="fig4">Figure 4B and H</xref>) was higher in the striatum of STING ki mice (<xref ref-type="fig" rid="fig4">Figure 4G and H</xref>); this difference was not statistically significant in the SN (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). Similarly, expression of <italic>Sting1</italic> was increased in the striatum of STING ki mice, but not in the SN (<xref ref-type="fig" rid="fig4">Figure 4C, I</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Activation of IFN and NF-κB/inflammasome related genes in the striatum and SN of STING ki mice.</title><p>(<bold>A–C</bold>) Expression of ISGs in the substantia nigra of STING WT and STING ki mice. (<bold>A</bold>) <italic>Iﬁ44</italic> (p=0.1552, n=4–5), (<bold>B</bold>) <italic>Mx1</italic> (Mann Whitney test, p=0.9048, n=4–5), (<bold>C</bold>) <italic>Sting1</italic> (<italic>P</italic>=0.9184, n=4–5). (<bold>D–F</bold>) Expression of NF-κB/inflammasome related genes in the substantia nigra of STING WT and STING ki mice. (<bold>D</bold>) <italic>Tnfa</italic> (p=0.0691, n=4–5), (<bold>E</bold>) <italic>Il1b</italic> (Mann Whitney test, *: p=0.0159, n=4–5), (<bold>F</bold>) <italic>Casp1</italic> (**: p=0.0018, n=4–5). (<bold>G–L</bold>) Expression of ISGs in the striatum of STING WT and STING ki mice. (<bold>G</bold>) <italic>Iﬁ44</italic> (**: p=0.0078, n=3–4), (<bold>H</bold>) <italic>Mx1</italic> (*: p=0.0183, n=3–4), (<bold>I</bold>) <italic>Sting1</italic> (*: p=0.024, n=3–4). (<bold>J–L</bold>) Expression of NF-κB/inflammasome related genes in the striatum of STING WT and STING ki mice. (<bold>J</bold>) <italic>Tnfa</italic> (n=3–4), (<bold>K</bold>) <italic>Il1b</italic> (*: p=0.0397, n=3–4), (<bold>L</bold>) <italic>Casp1</italic> (**: p=0.0017, n=3–5). Markers represent individual animals, bars represent mean ± SD. Analysis was t-test, if not indicated otherwise.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Expression of IFN and NF-κB and inflammasome dependent genes in the cortex of juvenile and adult STING ki mice.</title><p>(<bold>A–D</bold>) Expression of ISGs in the frontal cortex of STING WT and STING ki mice. (<bold>A</bold>) <italic>Iﬁ44</italic> (***: p=0.0002277; *: p=0.044987, n=5), (<bold>B</bold>) <italic>Mx1</italic> (***: p=0.0000003; *: p=0.016835; for comparison between age groups ***: p=0.000602, n=4–5), (<bold>C</bold>) <italic>Cxcl10</italic> (***: p=0.000001; **: p=0.0017215; for comparison between age groups **: p=0.001483, n=4–5), (<bold>D</bold>) <italic>Sting1</italic> (*: p=0.0184042, n=4–5). (<bold>E–G</bold>) Expression of NF-κB/inflammasome related genes in the frontal cortex of STING WT and STING ki mice. (<bold>E</bold>) <italic>Tnfa</italic> (***: p=0.0001448, for comparison between age groups *: p=0.03952, n=5). (<bold>F</bold>) <italic>Il1b</italic> (***: p=0.00005, *: p=0.0389, for comparison between age groups **: p=0.00241, n=4–5). (<bold>G</bold>) <italic>Casp1</italic> (***: p=0.0000369, for comparison between age groups ***: p=0.000064, n=4–5). Markers represent individual animals, bars represent mean ± SD. Analysis was two-way ANOVA with Tukey HSD post-hoc test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig4-figsupp1-v2.tif"/></fig></fig-group><p>cGAS/STING activation also leads to the activation of the NF-κB and inflammasome pathways (<xref ref-type="bibr" rid="bib2">Balka et al., 2020</xref>; <xref ref-type="bibr" rid="bib3">Balka and De Nardo, 2021</xref>; <xref ref-type="bibr" rid="bib76">Wang et al., 2020</xref>). We therefore analysed induction of the NF-κB and inflammasome pathways by quantitative real time PCR of the downstream mediators, tumour necrosis factor alpha (<italic>Tnfa</italic>), interleukin 1 beta (<italic>Il1b</italic>), and caspase-1 (<italic>Casp1</italic>). The average expression of <italic>Tnfa</italic> was higher in STING ki mice compared to STING WT mice, but the difference was not statistically significant (<xref ref-type="fig" rid="fig4">Figure 4D and J</xref>). In contrast, expression <italic>Il1b</italic> and <italic>Casp1</italic> was significantly higher both in SN and in striatum (<xref ref-type="fig" rid="fig4">Figure 4E, F, K and L</xref>). Upregulation of inflammatory mediators was also observed in juvenile mice and in cortical lysates (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Collectively, these findings are consistent with differential activation of IFN-dependent and IFN independent signalling between brain regions, but further work will be needed to confirm this.</p></sec><sec id="s2-5"><title>Pro-inflammatory transcription factors translocate to the nucleus in STING ki mice</title><p>Nuclear trafficking is critical for the function of transcription factors such as STAT3 and NF-κB (<xref ref-type="bibr" rid="bib3">Balka and De Nardo, 2021</xref>; <xref ref-type="bibr" rid="bib52">Noguchi et al., 2013</xref>). To confirm the activation of the type I IFN and NF-κB-dependent pathways in STING ki mice by another method, we therefore quantified the number of nuclei positive for phosphorylated STAT3 (pSTAT3, <xref ref-type="fig" rid="fig5">Figure 5A and C</xref>) and for the NF-κB p65 subunit (<xref ref-type="fig" rid="fig5">Figure 5B and D</xref>) in the striatum of juvenile and adult mice. There were only very few pSTAT3-positive nuclei in juvenile and adult STING WT mice (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). In juvenile STING ki mice, the average number of pSTAT3-positive nuclei was fourfold higher than in juvenile STING WT mice (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, p=0.05678, twoway ANOVA). In adult STING ki mice, the number of pSTAT3-positive nuclei was 15-fold higher than in adult STING WT (p=0.00004). The number of NF-κB-positive nuclei was threefold higher in juvenile STING ki mice than in juvenile STING WT (<xref ref-type="fig" rid="fig5">Figure 5B</xref> and, p=0.009). In adult STING ki mice, the number of NF-kB-positive nuclei was sixfold higher than in adult STING WT (<xref ref-type="fig" rid="fig5">Figure 5D</xref>, p=0.007). Since many of the pSTAT3-positive nuclei were negative for both Iba1 and GFAP (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), we next stained striatal sections for the neuronal marker NeuN to determine whether the pSTAT3-positive nuclei are neurons (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A, B</xref>). Indeed, 67% of NeuN-positive neurons were also positive for pSTAT3 in STING ki animals and only 1% in STING WT (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). In fact, neuronal nuclei represent the majority of nuclear pSTAT3 signal (85% in STING WT and 95% in STING ki, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Nuclear translocation of pSTAT3 and NF-κB in the striatum of 5-week-old and 20 week-old STING WT and STING ki mice.</title><p>(<bold>A</bold>) Representative images of striatal sections from 5-week-old (upper images) and 20-week-old (lower images) STING WT and STING ki mice stained for Iba1 (green), GFAP (white) and phosphorylated-STAT3 (pSTAT3; red). Images show color coded merged channels (center) and in addition pSTAT3 staining in grayscale (left and right). Scale bar: 10 μm. (<bold>B</bold>) Representative images of striatal sections from 5-week-old (upper images) and 20 week-old (lower images) STING WT and STING ki mice stained for Iba1 (green), GFAP (white), and NF-κB (red). NF-kB staining is shown in grey in separate images. Scale bar: 10 μm. (<bold>C</bold>) Number of pSTAT3-positive nuclei/mm<sup>3</sup> (***: p=0.00004; **: p=0.0025 for the interaction; two-way ANOVA, Bonferroni post-hoc test, n=5). (<bold>D</bold>) Number of NF-kB-positive nuclei/mm<sup>3</sup> (**: p=0.009; ***: p=0.0007; mean ± SD; two-way ANOVA, Bonferroni post-hoc test, n=5).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Uncropped membranes showing the levels of inflammatory proteins in the striatum.</title><p>(<bold>A</bold>) Representative images of striatal sections from 20-week-old STING WT and STING ki mice stained for phosphorylated-STAT3 (pSTAT3, magenta), Iba1 (blue) and NeuN (green). Images show color-coded merged channels (left) and in addition all channels in grayscale (right). Scale bar: 20 μm. (<bold>B</bold>) Ratio of NeuN-positive cells positive for pSTAT3 as well: (number of pSTAT3- and NeuN-positive cells)/(total number of NeuN-positve cells); (****: p=0.000065; t-test). (<bold>C</bold>) Ratio of neuronal pSTAT3-positive nuclei: (number of pSTAT3- and NeuN-positive cells)/(total number of pSTAT3-positve cells); **: p=0.0025; t-test. n=4.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig5-figsupp1-v2.tif"/></fig></fig-group><p>Taken together, our results show nuclear translocation of pSTAT3 and NF-κB in the striatum of STING ki mice, consistent with a robust activation of type I IFN and NF-κB signalling in STING ki mice.</p><p>We next assessed nuclear translocation of interferon regulatory factor 3 (IRF3) in striatal lysates obtained from adult STING WT and STING ki mice using subcellular fractionation (<xref ref-type="fig" rid="fig6">Figure 6A</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Proper separation of cytosol and nuclei was confirmed by observing HDAC6 exclusively in the nuclear fraction and GAPDH exclusively in the cytosolic fraction. IRF3 was mainly found in the cytosolic fraction of STING WT lysates, but mainly in the nuclear fraction of STING ki lysates (quantified in <xref ref-type="fig" rid="fig6">Figure 6B</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>). This finding suggests that IRF3 translocates to the nucleus in STING ki mice, similar to pSTAT3 and NF-κB (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Furthermore, we investigated the contribution of the type I IFN and inflammasome signaling pathways to neuroinflammation in STING ki mice. In order to test the involvement of the IFN dependent pathway, we crossed STING ki mice with mice deficient for type I IFN receptor (<italic>Ifnar1<sup>-/-</sup></italic>); in order to test the involvement of the inflammasome pathway, we crossed STING ki mice with mice deficient for caspase-1 (<italic>Casp1</italic><sup>-/-</sup>). Nuclear translocation of IRF3 in STING ki mice was preserved in animals deficient for type I IFN receptor (<italic>Ifnar1<sup>-/-</sup></italic>), consistent with the notion that IFN signal downstream of IRF3. IRF3 translocation was also preserved in mice deficient for caspase-1 (<italic>Casp1</italic><sup>-/-</sup>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Activation of IRF3 and NF-kB-related signalling pathways in double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1.</title><p>(<bold>A</bold>) Representative western blot images showing interferon regulatory factor 3 (IRF3, upper panel), the nuclear marker histone deacetylase 1 (HDAC1, middle panel) and cytoplasmic marker glycerinaldehyd-3-phosphat-dehydrogenase (GAPDH, lower panel) detected from the striatum. Images of the whole membrane stained for the different proteins are shown on <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A-C</xref>. (<bold>B</bold>) Ratio of IRF3 and HDAC1, expressed as relative to the mean of STING WT (****: p&lt;0.00001; **: p=0.0043; two-way ANOVA with Tukey post-hoc test, n=4). Ratio of IRF3 and GAPDH expressed as relative to the mean of STING WT is shown on <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>. (<bold>C</bold>) Representative western blot images showing NLR family pyrin domain containing 3 (NLRP3, upper panel), Il1b and pro-Il1b (middle panel) and the loading control βIII tubulin (lower panel) detected from the striatum. Images of the whole membrane stained for the different proteins are shown on <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E-H</xref>. (<bold>D</bold>) Ratio of NLRP3 and βIII tubulin, expressed as relative to the mean of STING WT (**: p&lt;0.0057; **: p=0.0029; two-way ANOVA with Tukey post-hoc test, n=4). (<bold>E</bold>) Ratio of Il1b and pro-Il1b, expressed as relative to the mean of STING WT (****: p&lt;0.00001; two-way ANOVA with Tukey post-hoc test, n=4). (<bold>F</bold>) Representative images of striatal sections stained for the astroglia marker GFAP (green), microglia marker Iba1 (magenta), apoptosis-associated speck-like protein (ASC, cyan) and Hoechst (blue) from STING WT or STING ki mice on a background of interferon a receptor knockout (<italic>Ifnar1<sup>-/-</sup></italic>), caspase-1 knockout (<italic>Casp1<sup>-/-</sup></italic>) or <italic>Ifnar1<sup>+/+</sup></italic>, <italic>Casp1<sup>+/+</sup></italic> (Ctrl.). Scale bar: 20 μm. Magnified insets show Iba1 and ASC, cyan arrowheads indicate ASC specks. (<bold>G</bold>) Area fraction of ASC signal within microglia as relative to the mean of STING WT (****: p&lt;0.00001; two-way ANOVA with Tukey post-hoc test, n=4–5). (<bold>H</bold>) Number of ASC-positive dots within microglia as relative to the mean of STING WT (****: p&lt;0.00001; two-way ANOVA with Tukey post-hoc test, n=4–5). (<bold>I</bold>) Number of ASC-positive dots within astroglia as relative to the mean of STING WT (**: p=0.0083; ***: p=0.0006; two-way ANOVA with Tukey post-hoc test, n=4–5). Graph showing area fraction of ASC signal within astroglia is on <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1I</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Uncropped membranes showing the levels of inflammatory proteins in the striatum.</title><p>(<bold>A–C</bold>) Images of the whole membrane developed for the HDAC1 (<bold>A</bold>), GAPDH (<bold>B</bold>) and IRF3 signals. (<bold>D</bold>) Ratio of IRF3 and GAPDH signal (‘cytoplasmic IRF3’) as relative to the mean of STING WT (two-way ANOVA with Tukey HSD post-hoc test, n=4). (<bold>E–H</bold>) Images of the whole membrane developed for the NLRP3 and Il1b with short exposure time (<bold>E</bold>) or longer exposure time (<bold>F</bold>); and for βIII tubulin (<bold>H</bold>). Membrane was cut between the NLRP3 and tubulin signals. (<bold>I</bold>) Area fraction positive for ASC signal within GFAP-positive astroglia, as relative to the mean of STING WT (****: p&lt;0.00001; *: p=0.038, two-way ANOVA with Tukey HSD post-hoc test, n=4–5). (<bold>J</bold>) Mean intensity of ASC signal in GFAP-positive or in Iba1-positive cells, expressed as relative to astroglial ASC signal in STING WT animals (***: p=0.0001; ****: p=0.000054; interaction: ****: p=0.000078, n=4–5).</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Individual, uncropped membranes.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-81943-fig6-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig6-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Inflammasomes are activated in STING ki mice</title><p>In order to determine whether inflammasomes are activated in STING ki mice, we first measured the abundance of NLRP3 protein in striatal lysates (<xref ref-type="fig" rid="fig6">Figure 6C</xref>, quantified in D, and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1F</xref>). NLRP3 immunoreactivity was higher in lysates of STING ki mice than in STING WT. This difference was preserved in <italic>Ifnar1<sup>-/-</sup></italic> mice, but lost in <italic>Casp1</italic><sup>-/-</sup> mice, consistent with the fact that formation of inflammasomes results in caspase-1 activation followed by Il1b release. Inflammasome formation in mice requires priming via NF-κB to induce expression of the scaffold protein NLRP3 (<xref ref-type="bibr" rid="bib5">Bauernfeind et al., 2009</xref>; <xref ref-type="bibr" rid="bib8">Broz and Dixit, 2016</xref>). This priming is reduced in <italic>Casp1</italic><sup>-/-</sup> mice due to the reduction of Il1b cleavage and release and, hence, less NF-κB activation. In addition, cleavage of pro-Il1b was activated in STING ki mice as compared to STING WT (<xref ref-type="fig" rid="fig6">Figure 6C</xref>, quantified in E, and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1F</xref>). This difference was preserved in <italic>Ifnar1<sup>-/-</sup></italic> mice, but lost in <italic>Casp1</italic><sup>-/-</sup> mice, consistent with the fact that pro-Il1b cleavage is mediated by caspase-1.</p><p>To confirm that inflammasomes are activated in STING ki mice, we stained for the inflammasome scaffold apoptosis-associated speck-like protein containing a CARD (ASC). ASC-positive puncta were observed in Iba1-positive and in GFAP-positive cells of striatal slices (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). Both the area fraction of ASC staining (<xref ref-type="fig" rid="fig6">Figure 6G</xref>) and the number of puncta within Iba1-positive cells (<xref ref-type="fig" rid="fig6">Figure 6H</xref>) was higher in slices of adult STING ki mice than in STING WT. ASC-positive dots were also observed in GFAP-positive cells, but not as frequently as in Iba1-positive cells (<xref ref-type="fig" rid="fig6">Figure 6I</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1I</xref>). This is consistent with the higher mean intensity of the total ASC signal observed in Iba1-positive cells compared to GFAP-positive cells (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1J</xref>). Inflammasome activation, as reported by ASC staining, was preserved in <italic>Ifnar1<sup>-/-</sup></italic> mice but absent in <italic>Casp1</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig6">Figure 6G–I</xref>), consistent with the findings obtained using immunoblots (<xref ref-type="fig" rid="fig6">Figure 6C–E</xref>).</p></sec><sec id="s2-7"><title>Type I IFN and inflammasome signaling contribute to neuroinflammation in STING ki mice</title><p>To further explore the interaction between inflammatory pathways for neuroinflammation in our STING ki mice, we measured the expression of ISGs, microglia-polarization related genes and concentrations of 13 cytokines and chemokines (summarized in <xref ref-type="fig" rid="fig7">Figure 7A</xref>). For practical reasons, ISG expression was measured in cortical lysates (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>) whereas cytokines and genes related to microglia polarisation were measured in striatal lysates (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). The N153S STING-induced increase in the interferon dependent genes <italic>Ifi44</italic> and <italic>Mx1</italic> was abrogated in <italic>Ifnar1</italic><sup>-/-</sup> mice, but unaltered in <italic>Casp1</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A, B</xref>), consistent with the dependence of <italic>Ifi44</italic> and <italic>Mx1</italic> on type I interferon signalling. Conversely, the N153S STING-induced increase in expression of <italic>Il1b</italic> was reduced in <italic>Casp1</italic><sup>-/-</sup> mice, but not in <italic>Ifnar1</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>), consistent with the fact that <italic>Il1b</italic> expression is inflammasome-dependent. The N153S STING-induced increase in <italic>Cxcl10</italic> expression was present on all backgrounds (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1D</xref>). Expression of <italic>Tnfa</italic> and <italic>Sting1</italic> was not different between STING ki and STING WT in adult mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1E, F</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Neuroinflammation in adult double transgenic mice with STING ki and knock-out for Ifnar1 or Caspase-1.</title><p>(<bold>A</bold>) Heatmap showing z-scores of different inflammatory markers in double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1. Graphs with data for each mediator individually are on (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). (<bold>B</bold>) Representative images of striatal sections stained for the microglia marker Iba1. Sections were obtained from adult STING WT (upper images) or STING ki (lower images) mice on a background of interferon a receptor knockout (<italic>Ifnar1<sup>-/-</sup></italic>), caspase-1 knockout (<italic>Casp1<sup>-/-</sup></italic>) or <italic>Ifnar1<sup>+/+</sup></italic>, <italic>Casp1<sup>+/+</sup></italic> (Ctrl.). Scale bar: 50 μm. (<bold>C</bold>) Representative images of striatal sections stained for the astroglia marker GFAP from STING WT (upper images) or STING ki (lower images) mice on a background of interferon a receptor knockout (<italic>Ifnar1<sup>-/-</sup></italic>), caspase-1 knockout (<italic>Casp1<sup>-/-</sup></italic>) or <italic>Ifnar1<sup>+/+</sup></italic>, <italic>Casp1<sup>+/+</sup></italic> (Ctrl.). Scale bar: 50 μm. (<bold>D</bold>) Area fraction positive for Iba1, normalized to the mean of STING WT brains (differences in <sup>+/+</sup> mice ***: p=0.0000001; for <italic>Ifnar1<sup>-/-</sup></italic> ***: p=0.000003; for <italic>Casp1<sup>-/-</sup></italic> ***: p=0.0029374; two-way ANOVA with Bonferroni post-hoc test, n=5–6). (<bold>E</bold>) Area fraction positive for GFAP, normalized to STING WT on Ctrl. Background (***: p=0.0000 for STING WT vs STING ki on Ctrl.; ***: p=0.0000 on <italic>Ifnar1<sup>-/-</sup></italic>; background, ***: p=0.0006 on Casp1-/- background; two-way ANOVA with Bonferroni post-hoc test, n=5–6).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Expression of IFN- and NF-κB/inflammasome related genes in the cortex of double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1.</title><p>Gene expression in the cortex (two-way ANOVA with Tukey HSD post-hoc test). (<bold>A</bold>) <italic>Ifi44</italic> (*: p=0.01414; **: p=0.0037655; for interaction between Ctrl. and <italic>Ifnar1<sup>-/-</sup></italic>, **: p=0.005101, n=4–5). (<bold>B</bold>) <italic>Mx1</italic> (*: p=0.02823; **: p=0.00573, n=4–5). (<bold>C</bold>) <italic>Il1b</italic> (Ctrl. background *: p=0.04534; **: p=0.005405; <italic>Casp1<sup>-/-</sup> background</italic> *: p=0.0107096; for interaction between Ctrl. and <italic>Casp1<sup>-/-</sup></italic>, *: p=0.01298, n=4–5). (<bold>D</bold>) <italic>Cxcl10</italic> (Ctrl. background **: p=0.0030844; <italic>Ifnar1<sup>-/-</sup></italic> background: p=0.025893; <italic>Casp1<sup>-/-</sup> background</italic> **: p=0.0041598, n=4–5). (<bold>E</bold>) <italic>Tnfa</italic> (all differences n.s., n=4–5). (<bold>F</bold>) <italic>Sting1</italic> (all differences n.s., n=4–5).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig7-figsupp1-v2.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Levels of inflammatory mediators and gene expression in the striatum of double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1.</title><p>(<bold>A–M</bold>) Tissue levels of different ‘M1’ and ‘M2’ mediators in the striatum as measured by LegendPlex Immunoassay (ANOVA with Tukey HSD post-hoc test). (<bold>A</bold>) IFNα (*: p=0.0394; for interaction: *: p=0.0465); (<bold>B</bold>) IFNγ (*: p=0.0194); (<bold>C</bold>) Cxcl9 (*: p=0.0129); (<bold>D</bold>) Cxcl10 (*: p=0.0223); (<bold>E</bold>) CCL3 (***: p=0.0009); (<bold>F</bold>) CCL2 (*: p=0.0264); (<bold>G</bold>) TNFα; (<bold>H</bold>) IL-6; (<bold>I</bold>) CCL4; (<bold>J</bold>) Il4; (<bold>K</bold>) IL-10; (<bold>L</bold>) GM-CSF; (<bold>M</bold>) VEGF; (<bold>N–Q</bold>) Gene expression in the striatum (two-way ANOVA with Tukey HSD post-hoc test). (<bold>N</bold>) <italic>Nos2</italic> (*: p=0.0214). (<bold>O</bold>) <italic>Ym-1</italic> (***: p=0.0004). (<bold>P</bold>) <italic>Il4</italic>. (<bold>Q</bold>) <italic>Retnla, b or g</italic> (p=0.021). (<bold>R</bold>) Principal component analysis (PCA) of immune mediators shows segregation of STING ki animals on the <italic>Ifnar1<sup>+/+</sup></italic>, <italic>Casp1<sup>+/+</sup></italic> (ki) and on the <italic>Ifnar1<sup>-/-</sup></italic> (<italic>Ifnar1<sup>-/-</sup></italic> ki) from all other groups. n=4–6.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig7-figsupp2-v2.tif"/></fig></fig-group><p>Activated microglia can exert a continuum of phenotypes between the pro-inflammatory ‘M1’ phenotype and an ‘M2’ phenotype associated with trophic factors and tissue repair (<xref ref-type="bibr" rid="bib36">Keren-Shaul et al., 2017</xref>; <xref ref-type="bibr" rid="bib55">Orihuela et al., 2016</xref>). We therefore characterized the effect of STING ki on microglia activation – with and without depletion of <italic>Ifnar1</italic> or <italic>Casp1</italic> – in striatal lysates (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). For most cytokines, the concentration was higher in lysates of STING ki mice (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). When analysed individually, the N153S STING-induced increase was more pronounced in <italic>Ifnar1</italic><sup>-/-</sup> mice, notably for the ‘M1’ markers IFNα, IFNγ, Cxcl9, Cxcl10, CCL3, and CCL2 (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2A-F</xref>). The concentration of TNFα protein was unaltered (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2G</xref>), consistent with the unaltered gene expression (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1E</xref>). Also, we did not observe a significant difference between STING ki and STING WT for IL-6, CCL4, Il4, IL-10, GM-CSF and VEGF (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2H-M</xref>). As for gene expression in the striatum, on the <italic>Ifnar1<sup>-/-</sup></italic> background, both the ‘M1’ marker <italic>Nos2</italic> and the ‘M2’ marker <italic>Ym-1</italic> were higher in STING ki mice than in STING WT (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2N, O</xref>). On WT background and in <italic>Casp1<sup>-/-</sup></italic>mice, the differences between STING ki and STING WT were not statistically significant, similar to the observations with the protein levels of cytokines. Expression of the ‘M2’ markers Il4 and <italic>Retnlb</italic> was not altered (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2P, Q</xref>).</p><p>A principal component analysis of all measured parameters (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2R</xref>) shows STING ki as the main contributor of the first component and the WT background as the main contributor of the second component. A heatmap of z-transformed values for all parameters (<xref ref-type="fig" rid="fig7">Figure 7A</xref>) shows a marked difference between STING ki and STING WT animals on WT background and in <italic>Ifnar1<sup>-/-</sup></italic> mice but not in <italic>Casp1<sup>-/-</sup></italic> mice.</p><p>Collectively, these findings suggest a more prominent role for the caspase-1 dependent inflammasome pathway for the N153S STING-dependent activation of the inflammatory mediators we measured. In order to determine functional significance for neuroinflammation, we next measured glial activation in <italic>Ifnar1<sup>-/-</sup></italic> and <italic>Casp1</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig7">Figure 7B and C</xref>).</p><p>For microglia, N153S STING-induced activation of microglia was still observed in adult <italic>Ifnar1<sup>-/-</sup></italic> and <italic>Casp1</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig7">Figure 7B and D</xref>, fold increase and p values in legend). In order to determine whether the extent of N153S STING-induced microglia activation was significantly different between <italic>Ifnar1<sup>-/-</sup></italic> mice and Ctrl., we calculated the interaction between the factors ‘STING genotype’ and ‘<italic>Ifnar1</italic> genotype’ in two-way ANOVA. The extent of microglia activation was significantly smaller in adult <italic>Ifnar1<sup>-/-</sup></italic> mice (p=0.004724) than in Ctrl. Similarly, the extent of N153S STING-induced microglia activation was significantly smaller in <italic>Casp1</italic><sup>-/-</sup> mice (p=0.000021). Furthermore, the extent of N153S STING-induced microglia activation did not differ between <italic>Ifnar1<sup>-/-</sup></italic> and <italic>Casp1</italic><sup>-/-</sup> (p=0.0805731). N153S STING-induced microglia activation therefore depends both on type 1 IFN signalling and on inflammasome signalling.</p><p>For astroglia (<xref ref-type="fig" rid="fig7">Figure 7C and E</xref>), the extent of N153S STING-induced activation was significantly reduced from 26-fold in Ctrl. to 16-fold in <italic>Ifnar1<sup>-/-</sup></italic> (p=0.0158378 for interaction of twoway ANOVA) and to fourfold in <italic>Casp1</italic><sup>-/-</sup> (p&lt;0.00001 for interaction of twoway ANOVA). In fact, no statistically significant N153S STING-induced activation of astroglia was observed on the <italic>Casp1</italic><sup>-/-</sup> background. These findings suggest that astroglia activation might depend more on inflammasome signalling than on type I IFN-dependent signalling.</p></sec><sec id="s2-8"><title>Oxidative stress in STING ki mice</title><p>Neuroinflammation can be associated with oxidative stress, and dopaminergic neurons are particularly sensitive to oxidative stress. We therefore measured reactive oxygen species (ROS) in lysates obtained from the striatum of adult mice. Mitochondrial ROS levels were higher in STING ki than in STING WT (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). Similarly, cytoplasmatic ROS levels were increased in STING ki as compared to STING WT (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). The N153S STING-induced increase was also observed on the <italic>Ifnar1<sup>-/-</sup></italic> background, but not on the <italic>Casp1</italic><sup>-/-</sup> background. To report the activity of the (inducible) nitric oxide synthase, we measured the concentration of nitrite in the striatal lysates (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). As for ROS, the nitrite concentration was higher in lysates of STING ki mice than in STING WT; this difference was also observed on <italic>Ifnar1<sup>-/-</sup></italic> and <italic>Casp1</italic><sup>-/-</sup> background.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Oxidative stress in the striatum of double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1.</title><p>(<bold>A</bold>) Mitochondrial reactive oxygen species (ROS) of striatal lysates determined using MitoSOX and expressed relative to the mean of STING WT (**: p=0.0072; ****: p&lt;0.00001; two-way ANOVA with Tukey post-hoc test, n=4). (<bold>B</bold>) Cytoplasmic ROS of striatal lysates determined using DCFH-DA and expressed relative to the mean of STING WT (****: p&lt;0.00001; *: p=0,034; **: p=0.0069; two-way ANOVA with Tukey post-hoc test, n=4). (<bold>C</bold>) Nitrite levels as markers of nitric oxide activity measured in striatal lysates (****: p&lt;0.00001; **: p=0.0052; two-way ANOVA with Tukey post-hoc test, n=4–5).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig8-v2.tif"/></fig><p>Taken together, these findings demonstrate increased oxidative stress in the brain of STING ki mice, which constitutes a potential mechanism by which neuroinflammation might contribute to the degeneration of dopaminergic neurons (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="s2-9"><title>Type I IFN and inflammasome signalling contribute to neurodegeneration in STING ki mice</title><p>Overall, several parameters of neuroinflammation were blunted in <italic>Casp 1</italic> <sup>/-</sup> mice, but not in <italic>Ifnar1<sup>-/-</sup></italic> mice. We wanted to use this difference to examine the question whether activation of type I IFNs or inflammasomes is more important for degeneration of dopaminergic neurons (<xref ref-type="fig" rid="fig9">Figure 9</xref>.). Unfortunately, however, the density of dopaminergic axon terminals in the striatum was already lower in <italic>Ifnar1<sup>-/-</sup></italic> mice and <italic>Casp 1</italic> <sup>/-</sup> mice with WT STING than in control <italic>Ifnar1<sup>+/+</sup></italic> and <italic>Casp1</italic><sup>+/+</sup> mice (p=0.0143071 and p=0.0000248, two-way ANOVA). These findings suggest that <italic>Ifnar1</italic> and <italic>Casp1</italic> are required for proper proliferation, maturation and/or maintenance of dopaminergic neurons and their axon terminals. Indeed, the Wnt-β-catenin pathway is regulated by interferons (<xref ref-type="bibr" rid="bib38">Kovács et al., 2019</xref>) and regulates the differentiation of midbrain dopaminergic neurons (<xref ref-type="bibr" rid="bib71">Szegő et al., 2017</xref>). Furthermore, Il1b induces the differentiation of dopaminergic neurons (<xref ref-type="bibr" rid="bib41">Ling et al., 1998</xref>; <xref ref-type="bibr" rid="bib63">Rodriguez-Pallares et al., 2005</xref>). We found marginally reduced <italic>Il1b</italic> expression in adult <italic>Casp1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>, STING WT), which could explain reduced density of dopaminergic fibers observed in <italic>Casp1<sup>-/-</sup></italic> mice.</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Degeneration of dopaminergic neurons in double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1.</title><p>(<bold>A</bold>) Representative images of striatal sections stained for tyrosine hydroxylase (TH) from STING WT (upper images) or STING ki (lower images) mice on a background of interferon a receptor knockout (<italic>Ifnar1<sup>-/-</sup></italic>), caspase-1 knockout (<italic>Casp1<sup>-/-</sup></italic>) or <italic>Ifnar1<sup>+/+</sup></italic>, <italic>Casp1<sup>+/+</sup></italic> (Ctrl.). Scale bar: 10 μm. (<bold>B</bold>) Area fraction positive for TH, normalized to STING WT on Ctrl. background (***: p=0.0000 for Ctrl. background; *: p=0.043 for <italic>Ifnar1<sup>-/-</sup></italic>; **: p=0.0126845 for <italic>Casp1<sup>-/-</sup></italic>; for interaction between Ctrl. background and <italic>Ifnar1<sup>-/-</sup></italic>: p=0.00157; between Ctrl. and <italic>Casp1<sup>-/-</sup></italic>: p=0.007326; two-way ANOVA with Bonferroni post-hoc test, n=5–6). (<bold>C</bold>) Concentration of dopamine in striatal lysates of STING WT and STING ki mice, normalized to STING WT on Ctrl. background. (***: p=0.0005; t-test, n=5–6). Dopamine metabolism is shown on <xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig9-v2.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title>Dopamine metabolism in the striatum of double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1.</title><p>Dopamine metabolism in the striatum (**: p=0.0073; two-way ANOVA, Tukey HSD post-hoc test, n=3–8).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-fig9-figsupp1-v2.tif"/></fig></fig-group><p>Both in <italic>Ifnar1<sup>-/-</sup></italic> and in <italic>Casp 1</italic> <sup>/-</sup> mice, the N153S STING-induced degeneration of dopaminergic axon terminals in the striatum was less pronounced than in the control <italic>Ifnar1<sup>+/+-</sup></italic> and <italic>Casp1</italic><sup>+/+</sup> mice (<xref ref-type="fig" rid="fig9">Figure 9A and B</xref>; p=0.00157 and p=0.007326 for interaction in two-way ANOVA). N153S STING-induced fibre loss was not statistically different between <italic>Ifnar1<sup>-/-</sup></italic> and <italic>Casp1</italic><sup>-/-</sup> mice (p=0.468 for interaction). Consistent with the less pronounced degeneration of dopaminergic axon terminals, the N153S STING-induced reduction in striatal dopamine was not observed in <italic>Ifnar1<sup>-/-</sup></italic> and <italic>Casp1</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig9">Figure 9C</xref> and <xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1</xref>). These findings suggest that both pathways contribute to the degeneration of dopaminergic axon terminals, and blocking either pathway could reduce neurodegeneration.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this work, we demonstrated that the expression of the constitutively active STING variant N153S causes neuroinflammation, which is followed by degeneration of dopaminergic neurons and aSyn pathology. N153S STING-induced microglia activation and degeneration of dopaminergic neurons involve type I IFN and inflammasome-mediated signalling; astroglia activation might depend predominantly on the inflammasome pathway.</p><sec id="s3-1"><title>Constitutive STING activation causes neuroinflammation</title><p>STING is expressed in the central nervous system. Its expression is highest in microglia, but it can also be detected in astroglia and neurons (<xref ref-type="bibr" rid="bib35">Jeffries and Marriott, 2017</xref>). Microglia are the primary immune cells of the central nervous system (<xref ref-type="bibr" rid="bib80">Wolf et al., 2017</xref>) and highly activated upon pathogen invasion or tissue damage. Microglia activation in juvenile (<xref ref-type="fig" rid="fig2">Figure 2</xref>) and adult (<xref ref-type="fig" rid="fig1">Figure 1</xref>) STING ki mice is therefore in line with the increased inflammatory phenotype found in the lungs and spleen of STING ki mice (<xref ref-type="bibr" rid="bib45">Luksch et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Siedel et al., 2020</xref>) and in patients with STING-associated vasculopathy with onset in infancy syndrome (<xref ref-type="bibr" rid="bib42">Liu et al., 2014</xref>). SAVI patients may suffer from various neurological symptoms, including calcification of basal ganglia, but neurological symptoms are not a core feature of the human SAVI disease (<xref ref-type="bibr" rid="bib20">Frémond et al., 2021</xref>).</p><p>Consistent with this morphologically defined neuroinflammatory phenotype, we observed increased expression of the ISGs <italic>Ifi44</italic> and <italic>Mx1</italic> in striatum and cortex (<xref ref-type="fig" rid="fig4">Figure 4G and H</xref> and supplement 1A, B). Moreover, we observed nuclear translocation of pSTAT3, which was already present in juvenile mice, but more prominent in adult mice (<xref ref-type="fig" rid="fig5">Figure 5C</xref>), and nuclear translocation of IRF3 (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>). These effects are associated with IFN signalling, the main pathway downstream of STING (<xref ref-type="bibr" rid="bib15">Decout et al., 2021</xref>), and demonstrate that expressing the N153S mutant of STING indeed activates IFN-dependent pathways in these brain regions. Accordingly, microglia activation was reduced when N153S STING was expressed in mice deficient for <italic>Ifnar1</italic> (<italic>Ifnar1</italic><sup>-/-</sup>, <xref ref-type="fig" rid="fig7">Figure 7D</xref>), confirming that the type I IFN pathway is involved in STING-dependent microglia activation - as previously demonstrated by others (<xref ref-type="bibr" rid="bib78">Warner et al., 2017</xref>). However, microglia activation by N153S STING was not completely blocked in <italic>Ifnar1<sup>-/-</sup></italic> mice, suggesting that additional pathways are involved.</p><p>Indeed, next to type I IFN signalling, we also observed nuclear translocation of NF-κB (<xref ref-type="fig" rid="fig5">Figure 5D</xref>), which was already prominent in juvenile mice, and suggests activation of NF-κB-dependend signalling in STING ki mice. Additionally, we observed increased expression of the NF-κB target genes <italic>Il1b</italic> (<xref ref-type="bibr" rid="bib32">Hiscott et al., 1993</xref>) and <italic>Tnfa</italic> (<xref ref-type="bibr" rid="bib12">Collart et al., 1990</xref>). Expression of <italic>Il1b</italic> was significantly increased in lysates of SN (<xref ref-type="fig" rid="fig4">Figure 4E</xref>), striatum (<xref ref-type="fig" rid="fig4">Figure 4K</xref>) and cortex (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>). For <italic>Tnfa,</italic> we observed a significant increase in juvenile STING ki (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>), but no significant change in adult mice (<xref ref-type="fig" rid="fig4">Figure 4D and J</xref>). Activation of the NF-κB pathway by STING is consistent with previous work by others (<xref ref-type="bibr" rid="bib84">Yum et al., 2021</xref>). Furthermore, increased expression of <italic>Il1b</italic> and <italic>Tnfa</italic> in a mouse model of TDP-43 proteinopathy was recently found to be STING dependent (<xref ref-type="bibr" rid="bib83">Yu et al., 2020</xref>).</p><p>One of the key signalling events downstream of STING and NF-κB is the activation of inflammasomes. Formation and activation of inflammasomes in STING ki mice was observed morphologically by quantification of ASC puncta (<xref ref-type="fig" rid="fig6">Figure 6F–I</xref>) and biochemically through Il1b cleavage (<xref ref-type="fig" rid="fig6">Figure 6C and E</xref>) and accumulation of NLRP3 (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>). Accordingly, the inflammasome dependent cleavage of Il1b was absent in STING ki mice with <italic>Casp1</italic> depletion (<xref ref-type="fig" rid="fig6">Figure 6C and F</xref>). The increased abundance of NLRP3 in STING ki mice was not observed in <italic>Casp1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig6">Figure 6D</xref>), suggesting that this regulation, too, results from inflammasome activation and not directly from NF-κB signalling. Inflammasome activation is consistent with previous work about systemic inflammation (<xref ref-type="bibr" rid="bib45">Luksch et al., 2019</xref>). The extent of microglia activation by N153S STING was reduced in <italic>Casp1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). Therefore, our results suggest that STING-dependent microglia activation involves inflammasome activation, in addition to type I IFN-dependent pathways. Activation of astroglia, in contrast, was completely blocked in <italic>Casp1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig7">Figure 7E</xref>), suggesting that STING-induced astroglia activation might depend mainly on inflammasome signalling. Mechanistically, astroglia activation could result directly from the expression of N153S STING in astroglia, but also indirectly through the activation of microglia (<xref ref-type="bibr" rid="bib39">Kwon and Koh, 2020</xref>; <xref ref-type="bibr" rid="bib80">Wolf et al., 2017</xref>). The differential effect in <italic>Ifnar1<sup>-/-</sup></italic> and <italic>Casp1<sup>-/-</sup></italic> mice suggests, however, that astroglia activation is not only a downstream consequence of microglia activation.</p></sec><sec id="s3-2"><title>Chronic STING activation leads to the degeneration of dopaminergic neurons</title><p>We observed a reduced number of TH-positive neurons in the substantia nigra of STING ki mice, a reduced density of dopaminergic axon terminals and a reduced concentration of striatal dopamine (<xref ref-type="fig" rid="fig1">Figure 1G–I</xref>). These changes occurred in adult mice and were not present in juvenile mice (<xref ref-type="fig" rid="fig2">Figure 2G–I</xref>). The degeneration of dopaminergic neurons thus is a consequence of the prolonged inflammatory changes in our model.</p><p>On the <italic>Ifnar1<sup>-/-</sup></italic> and <italic>Casp1<sup>-/-</sup></italic> backgrounds, the density of dopaminergic axon terminals was already reduced (<xref ref-type="fig" rid="fig9">Figure 9B</xref>), making it difficult to assess the effect of N153S STING. Nonetheless, the relative reduction in TH fibre density in STING ki mice, as compared to STING WT mice, was smaller on the <italic>Ifnar1<sup>-/-</sup></italic> and <italic>Casp1<sup>-/-</sup></italic> backgrounds than in controls (<xref ref-type="fig" rid="fig9">Figure 9B</xref>), as was the extent of dopamine depletion (<xref ref-type="fig" rid="fig9">Figure 9C</xref>). These findings are consistent with the partial rescue of microglia activation in <italic>Ifnar1<sup>-/-</sup></italic> and <italic>Casp1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig7">Figure 7D and E</xref>). They suggest that glia activation and secretion of inflammatory cytokines contribute to the degeneration of dopaminergic neurons – in line with previous findings demonstrating a role for inflammation in the pathogenesis of PD (<xref ref-type="bibr" rid="bib27">Hall et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Mollenhauer et al., 2019</xref>). In further studies, the developmental effects of <italic>Ifnar1</italic> and <italic>Casp1</italic> deficiency could be circumvented by using conditional knockout mice or pharmacological inhibitors. Oxidative stress was increased in STING ki mice (<xref ref-type="fig" rid="fig8">Figure 8</xref>) and cytoplasmic ROS were partially reduced in <italic>Casp1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig8">Figure 8B</xref>), suggesting that oxidative stress might contribute to the N153S STING-induced degeneration of dopaminergic neurons. In addition, constant STING activity within dopaminergic neurons could contribute to their degeneration – both in our STING ki mice and in the pathogenesis of PD. Indeed, dopaminergic neurons accumulate oxidative damage as a consequence of dopamine synthesis and electrical pacemaking activity (<xref ref-type="bibr" rid="bib26">Guzman et al., 2010</xref>), and even moderate oxidative stress can stimulate the STING pathway (<xref ref-type="bibr" rid="bib68">Sliter et al., 2018</xref>; <xref ref-type="bibr" rid="bib79">West et al., 2015</xref>).</p><p>Secreted immune mediators may trigger neuron loss upon STING activation (<xref ref-type="bibr" rid="bib50">Murthy et al., 2020</xref>). For instance, TNFR1 is a member of the death receptor family, and can induce the recruitment of TNFR1-associated death domain protein (TRADD) and apoptosis upon Tnfa binding (<xref ref-type="bibr" rid="bib34">Jayaraman et al., 2021</xref>; <xref ref-type="bibr" rid="bib50">Murthy et al., 2020</xref>). Indeed, inhibition of TRADD can restore proteostasis and inhibits mutant tau-induced cell death (<xref ref-type="bibr" rid="bib82">Xu et al., 2020</xref>). Next to Il1b cleavage, caspase-1 might also induce pyroptosis, an inflammatory form of cell death. After cleavage by caspase-1, gasdermin-D forms pores in the cell membrane (<xref ref-type="bibr" rid="bib66">Shi et al., 2017</xref>). Rupture of the plasma membrane leads to the release of cytoplasmic content into the extracellular space, further fuelling inflammatory response (<xref ref-type="bibr" rid="bib75">Voet et al., 2019</xref>). Furthermore, loss of ion gradient across the membrane makes neuronal functioning impossible. Besides increased oxidative stress or secreted immune mediators, neuronal STING activation may induce directly apoptosis. Emerging evidence suggests that STING activation induces endoplasmic reticulum (ER) stress and disrupt calcium homeostasis in various cell types (<xref ref-type="bibr" rid="bib14">Cui et al., 2016</xref>; <xref ref-type="bibr" rid="bib59">Petrasek et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">Wu et al., 2019</xref>), that, in turn, result in the loss of dopaminergic neurons (<xref ref-type="bibr" rid="bib25">Gong et al., 2019</xref>). Further work with cell-type specific N153S STING expression will be required to determine the importance of STING activation within dopaminergic neurons for their degeneration in this model.</p><p>The degeneration of dopaminergic neurons observed in these mice was not severe. Based on findings with other mouse models of PD by ourselves and others (<xref ref-type="bibr" rid="bib6">Bentea et al., 2015</xref>; <xref ref-type="bibr" rid="bib25">Gong et al., 2019</xref>; <xref ref-type="bibr" rid="bib53">Oliveras-Salvá et al., 2013</xref>), we do not expect a dopamine-dependent motor phenotype in these mice. Moreover, motor assessment is complicated by systemic inflammation in STING ki mice, affecting the lung and further organs (<xref ref-type="bibr" rid="bib45">Luksch et al., 2019</xref>).</p></sec><sec id="s3-3"><title>Accumulation of protein aggregates in STING ki mice</title><p>We observed an accumulation of phosphorylated and Triton X-100-insoluble aSyn, and an increased number of Thioflavin S positive cells in STING ki mice (<xref ref-type="fig" rid="fig3">Figure 3A–E</xref>). Collectively, these findings suggest that chronic STING activation induces aSyn pathology. They are consistent with the recent observation that priming rats with a mimic of viral dsDNA precipitates aSyn pathology (<xref ref-type="bibr" rid="bib54">Olsen et al., 2019</xref>) and with the aSyn aggregation following viral encephalitis (<xref ref-type="bibr" rid="bib4">Bantle et al., 2021</xref>). Inflammatory signals are therefore active promotors of aSyn pathology and not only responsive to aSyn pathology. Thioflavin S staining is, however, not specific for aSyn pathology, and STING-induced neuroinflammation could involve further proteins. Indeed, activation of NF-κB signalling in microglia was recently demonstrated to drive tau pathology (<xref ref-type="bibr" rid="bib77">Wang et al., 2022</xref>).</p><p>The mechanism by which prolonged neuroinflammation leads to aSyn pathology is still unknown. Both inflammation and IFN induce the expression of the double-stranded (ds) RNA-dependent protein kinase (PKR) (<xref ref-type="bibr" rid="bib24">Gal-Ben-Ari et al., 2018</xref>). PKR can phosphorylate aSyn at serine 129, resulting in aSyn pathology (<xref ref-type="bibr" rid="bib61">Reimer et al., 2018</xref>). Moreover, clearance of aSyn aggregates occurs primarily through autophagy (<xref ref-type="bibr" rid="bib16">Ebrahimi-Fakhari et al., 2011</xref>), and INFα increases expression of mammalian target of rapamycin (mTOR) (<xref ref-type="bibr" rid="bib43">Liu et al., 2016</xref>), which is expected to reduce autophagy initiation. On the other hand, acute STING activation can induce autophagy (<xref ref-type="bibr" rid="bib33">Hopfner and Hornung, 2020</xref>; <xref ref-type="bibr" rid="bib44">Liu et al., 2018</xref>; <xref ref-type="bibr" rid="bib48">Moretti et al., 2017</xref>). aSyn pathology in our model therefore could be explained by an exhaustion of the autophagy machinery, as it was suggested recently (<xref ref-type="bibr" rid="bib7">Bido et al., 2021</xref>), and the overall effect of inflammatory pathways on autophagy and aSyn pathology could be bimodal. Accordingly, degeneration of dopaminergic neurons and accumulation of aSyn aggregates was also observed in mice deficient for IFNβ (<xref ref-type="bibr" rid="bib17">Ejlerskov et al., 2015</xref>; <xref ref-type="bibr" rid="bib46">Magalhaes et al., 2021</xref>).</p></sec><sec id="s3-4"><title>Conclusions</title><p>This work provides evidence in a genetic model that chronic activation of STING signalling is sufficient for degeneration dopaminergic neurons. It has been demonstrated previously that blocking STING signalling or depleting STING is beneficial in animal models of ALS (<xref ref-type="bibr" rid="bib83">Yu et al., 2020</xref>) and PD (<xref ref-type="bibr" rid="bib68">Sliter et al., 2018</xref>). Yet, neuroinflammatory signalling involves many positive and negative feedback loops, so studies activating and blocking specific nodes are important to advance understanding and identify treatment targets. The interconnected nature and redundancy of neuroinflammation signalling was highlighted, for instance, by the strong inhibition of inflammasome signalling in <italic>Casp1<sup>-/-</sup></italic> mice, but the incomplete rescue of microglia activation and neurodegeneration.</p><p>This work is preliminary in many aspects. We have focused on dopaminergic neurons because we have been interested in pathways that cause their degeneration in the past, and STING has been linked to PD pathogenesis (<xref ref-type="bibr" rid="bib68">Sliter et al., 2018</xref>). Yet, STING-induced neurodegeneration is expected to affect further neuron populations, which need to be assessed in future studies. Indeed, STING-induced neuroinflammation was not restricted to the substantia nigra, but also observed, for instance, in the cortex. Also, Thioflavin S accumulation likely involves other proteins than aSyn. STING-induced neurodegeneration and proteinopathies therefore need to be assessed more systematically in future studies, addressing the question whether some brain regions and neuron populations are more susceptible to STING-induced damage than others. Finally, genetic activation of STING in cell-types will be required to delineate the contributions of STING activation within microglia and neurons.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><p>Source of chemicals, antibodies, composition of buffers, equipment and software used in this study are listed in the Key Resources Table.</p><sec id="s4-1"><title>Animals</title><p>All animal experiments were carried out in accordance with the European Communities Council Directive of November 24, 1986 (86/609/EEC) and approved by the Landesdirektion Dresden, Germany. Mice of both sexes were housed under a 12 hr light and dark cycle with free access to pelleted food and tap water in the Experimental Center, Technische Universität, Dresden, Germany. Heterozygous STING N153S/WT ki mice (STING ki) were previously described (<xref ref-type="bibr" rid="bib45">Luksch et al., 2019</xref>). STING ki or STING WT mice were crossed to <italic>Ifnar1</italic><sup>-/-</sup> mice (a gift from Axel Roers, Dresden, Germany; <xref ref-type="bibr" rid="bib67">Siedel et al., 2020</xref>) and <italic>Casp1</italic><sup>-/-</sup> mice (a gift from Stefan Winkler, Dresden, Germany ;<xref ref-type="bibr" rid="bib62">Reinke et al., 2020</xref>).</p><p>For all genotypes, five-week-old (from here referred as juvenile) or 20–23 week-old (referred as adult) animals were sacrificed with an overdose of isoflurane (Baxter, Lessines, Belgium). For analyses of proteins, gene expression, catecholamine and oxidative stress, brains were rapidly removed from the skull and washed in ice-cold Tris-buffered saline (TBS, pH 7.4). Cortex and striatum were dissected, snap-frozen in liquid nitrogen and stored at –80 °C until use. For histology, mice were perfused transcardially with 4% paraformaldehyde (PFA) in TBS. After post-fixation (4% PFA, overnight) and cryoprotection (30% sucrose in TBS), 30 µm-thick coronal brain sections were cut in a cryostat (Leica, Germany).</p></sec><sec id="s4-2"><title>Immunofluorescence stainings of mouse brain sections</title><p>To quantify the number of dopaminergic neurons in the substantia nigra (SN), every fifth section throughout the entire SN was stained for tyrosine hydroxylase (TH) as previously (<xref ref-type="bibr" rid="bib73">Szegő et al., 2021</xref>). In brief, after blocking (2% bovine serum albumin, 0,3% Triton X-100 in TBS; 1 hr RT), sections were incubated with the primary antibody in blocking solution (two overnights), followed by the fluorescently labelled secondary antibody (Alexa 488 conjugated donkey anti-sheep, 1:2000, overnight). Sections were counterstained with Hoechst and mounted with Fluoromount-G.</p><p>To quantify the density of dopaminergic axon terminals (fibers) and neuroinflammation in the striatum, every sixth section throughout the entire striatum was stained with a cocktail of primary antibodies: TH (Pel Freeze, P40101, 1:1000), Iba1 (Wako, 019–19741, 1:1000) and GFAP (abcam, ab4674, 1:2000). As fluorescently labelled secondary antibodies, Alexa 488 conjugated donkey anti-sheep, Alexa 555 conjugated donkey anti-rabbit, Alexa 647 conjugated donkey anti-chicken were used (1:2000, overnight). Sections were counterstained with Hoechst and mounted with Fluoromount-G.</p><p>To detect cells containing inclusions of β-sheet containing proteins, mounted brain sections were stained with 0.1% Thioflavin-S in 70% ethanol 25 min, rinsed in 80% ethanol for 5 min and in distilled water for 5 min. After staining the nuclei with NucSpot nuclear stain, sections were mounted in Fluoromount-G (<xref ref-type="bibr" rid="bib72">Szegő et al., 2019</xref>).</p><p>To quantify ASC-inflammasome assembly in glia cells, every tenth section throughout the entire striatum was stained with a cocktail of the following primary antibodies: ASC (Adipogen, 1:700, AG-25B-0006-C100), Iba1 (Synaptic Systems, 234004, 1:1000), and GFAP (abcam, ab4674, 1:2000). As fluorescently labelled secondary antibodies, Alexa 488 conjugated donkey anti-rabbit, Alexa 555 conjugated goat anti-guinea pig and Alexa 647 conjugated donkey anti-chicken were used (1:2000, overnight). Sections were counterstained with Hoechst and mounted with Fluoromount-G.</p></sec><sec id="s4-3"><title>Quantification of dopaminergic neuron number, striatal fiber density and gliosis</title><p>The number of dopaminergic somata in the SN was determined by supervised manual counting by an experienced investigator blinded to the experimental groups. For each animal, every fifth section throughout the rostro-caudal extent of the SN (2.54 to –3.88 mm posterior to Bregma based on <xref ref-type="bibr" rid="bib58">Paxinos and Franklin, 2001</xref>) was incorporated into the counting procedure. In each section, z stacks were acquired (step size: 2 µm, 5 slices in total) from both hemispheres with a 20 x objective (N.A 0.8, Axio Imager 2, Zeiss). Stacks were stitched to reconstruct the entire SN. After adjusting the threshold and carefully marking the borders of the SN, only TH-positive cell bodies with a visible nucleus in the blue channel were manually counted by ImageJ (1,53 c; Cell Counter plugin). All TH-positive neurons of each slices were counted. The total number of neurons for the entire SN of that hemisphere was estimated by multiplying the counted cell number by five, since every fifth section was used for this analysis.</p><p>For quantification of gliosis, five fluorescent images were acquired from every sixth striatal section stained for GFAP and Iba1 using a 20 x objective. After adjusting the threshold and noise removal (Background subtraction, rolling ball radius 50) from the individual images (separately for GFAP and Iba1 channels), the area fraction was determined by ImageJ from ten regions of interest per image. Results were analyzed using a generalized linear mixed model (glm) in RStudio with a hierarchically nested design (expressed as percent area) as previously (<xref ref-type="bibr" rid="bib73">Szegő et al., 2021</xref>).</p><p>From the same striatal sections, the density of the dopaminergic axon terminals (fibers) was determined as described previously (<xref ref-type="bibr" rid="bib70">Szego et al., 2012</xref>). In brief, z-stack images were acquired (five planes, 0.5 µm step size, 100 x objective, N.A. 1.4; Axio Imager 2, Zeiss). TH-positive fibers were delineated from the maximal intensity projection (ImageJ) after adjusting the threshold, noise removal and binarization, and density was expressed as percent area. Every sixth section per animal, five images per section and ten boxes per image were analyzed in a hierarchically nested design as above.</p><p>For quantification of the mean fluorescent intensity of the ASC signal, binary masks were first created (see above) separatly for microglia (Iba1 channel) and astroglia (GFAP channel). After removing background fluorescence (Background subtraction, rolling ball radius 50) from the individual ASC images, mean fluorescent intensity of the ASC signal was measured by ImageJ from all glia cells from a given microscope image. After adjusting the threshold of the ASC signal on the same individual images, area fraction of the ASC signal and the number of individual dots (ASC-specks) within microglia and within astroglia were also determined separately by ImageJ.</p></sec><sec id="s4-4"><title>Protein analyses</title><p>To detect protein changes, cortical and striatal tissue were mechanically lysed in a buffer containing 250 mM sucrose, 50 mM TRIS (pH 7,5), 1 mM EDTA, 5 mM MgCl<sub>2</sub>, 1% Triton X-100 in the presence of protease and phosphatase inhibitors (MedChem Express) as previously (<xref ref-type="bibr" rid="bib70">Szego et al., 2012</xref>). Samples were centrifuged (14,000 g, 30 min, 4 °C) and protein concentration in the supernatant was determined with the BCA method (ThermoFisher, Germany). After boiling with 4 x Laemmli buffer (1 M Tris pH 6.8, 0.8% SDS, 40% glycerol, 5% β-mercaptoethanol, traces of bromophenol blue, 5 min, 95 °C), 5 µg protein was loaded onto a 4–20% Tris/glycine SDS gel for western blot analysis. Membranes were fixed in paraformaldehyde (10 min, RT) and blocked with 1% bovine serum albumin, 0,05% Tween 20 in TBS. Membranes were incubated first in the presence of antibodies against phosphorylated aSyn and aSyn, (Cell Signaling), then with βIII-tubulin as loading control (overnight, 4 °C). Following washing, membranes were incubated in the presence of horseradish peroxidase-conjugated secondary antibodies (donkey anti-mouse or donkey anti-rabbit). Signal was detected using chemiluminescent substrate and a camera-based system. ImageJ was used to determine the optical density of protein bands and all data were analyzed for each group (n = 5 animals/group) based on 3 independent blots. Optical densities were normalized to the expression of the density of the tubulin loading control of the same sample, and then expressed relative to the WT animals.</p></sec><sec id="s4-5"><title>Triton X-100 solubility</title><p>For detection of aSyn in the Triton X-100 insoluble fraction, snap-frozen substantia nigra and striatal tissue were lysed in PBS containing 1% of Triton X-100, phosphatase inhibitors and protease inhibitors. Lysates were vortexed and incubated for 30 min at 4 °C. After centrifugation (14,000 g, 30 min, 4 °C), supernatant was used as Triton X-100 soluble fraction. The pellet was washed in ice-cold PBS, centrifuged again and re-dissolved with sonication (10 s) in 50 µl buffer containing 2% SDS, 75 mM Tris, 15% glycerin, 3.75 mM EDTA pH 7.4 and protease inhibitors. Solution was briefly centrifuged (5 min, 14 000 g, RT), and it was used as Triton X-100 insoluble fraction. 10 µg of Triton X-100 soluble lysate or 10 µl Triton X-100 insoluble fraction were loaded onto a 4–20% Tris/glycine SDS gel for western blot analysis, and processed as above to detect signals of aSyn and βIII-tubulin. To obtain the ratio of aSyn within the Triton X-100 soluble and insoluble fractions, data was normalized (1) to the tubulin loading control within line, then (2) to the soluble aSyn/tubulin ration, and finally (3) to the values of STING WT animals.</p></sec><sec id="s4-6"><title>Biochemical assays</title><p>Cytoplasmic reactive oxygen species (ROS) production and mitochondrial ROS production, total nitrite levels were measured as described previously (<xref ref-type="bibr" rid="bib56">Pais et al., 2013</xref>; <xref ref-type="bibr" rid="bib72">Szegő et al., 2019</xref>). In brief, striatal tissue were lysed in ice-cold in PBS and centrifuged (14,000 g, 30 min, 4 °C). Cytoplasmic ROS was measured using dichlorodihydroﬂuorescein diacetate (DCFH-DA; 10 mM, 37 C, 30 min), mitochondrial ROS was measured using MitoSOX (200 nM, 20 min, 37 C). Fluorescence at 485/530 nm (DCFH-DA) or 510/580 nm (MitoSox) was measured with plate reader. The production of NO by iNOS was measured indirectly by assaying nitrites in the lysate using the Griess reaction (<xref ref-type="bibr" rid="bib56">Pais et al., 2013</xref>). In brief, 10 µg of lysates were incubated with equal amount of Griess reagent (1% sulphanilamide, 0.1% naphthylethylenediamine in 2% phosphoric acid solution) for 20 min at room temperature. Absorbance was read at 550  nm.</p></sec><sec id="s4-7"><title>Gene expression analyses</title><p>Total RNA was extracted from snap frozen dissected prefrontal cortex tissue by using the RNeasy Mini Kit (Qiagen, Germany) according to the manufacturer’s instructions. cDNA was generated by MMLV reverse transcription (Promega Germany). Quantitative Real Time PCR assays were carried out by using QuantStudio 5 (Thermo Fisher Scientific, Germany) and GoTaqaPCR Master Mix with SYBR green fluorescence (Promega, Germany). PCR primer sequences were retrieved from the Primer Bank database (<xref ref-type="bibr" rid="bib69">Spandidos et al., 2010</xref>). Expression of genes was normalized to the expression of the housekeeping genes (<italic>Hprt1</italic>, <italic>Rpl13a</italic>, <italic>Eef2</italic>) and to the STING WT by using the ΔΔCt method. Sequences of primers are listed in the Key Resources Table.</p></sec><sec id="s4-8"><title>Legend Plex</title><p>LEGENDplex is a multiplex bead-based assay using the basic methodology of ELISA assay. Briefly, snap-frozen dissected STR tissue was homogenized in PBS add 0.5 % NP-40 and protease inhibitor cocktail (Sigma-Aldrich, Germany). The clarified supernatant after centrifugation was used for cytokine determination by Mouse cytokine release syndrome panel (Biolegend) according manufactures introductions. Quantity of cytokines was calculated per mg protein in each lysate.</p></sec><sec id="s4-9"><title>Statistical analyses</title><p>In graphs, markers represent individual animals; lines represent mean and standard deviation (SD) of all animals. Data normality was tested by the Kolmogorov-Smirnov test and graphically by QQ plot (R, version 2.8.0; <xref ref-type="bibr" rid="bib60">R Development Core Team, 2020</xref>). Grubbs test was used to identify outliers. t-test, Mann-Whitney test or two-way ANOVA were performed using GraphPad Prism (Versions 5.01 and 9.0.0). Linear regression and principal component analysis was performed using R (version 4.2.1.). For generalized linear mixed-effects model (<xref ref-type="bibr" rid="bib73">Szegő et al., 2021</xref>), animal, section and image were used as random effects nested within each other (R package: lme4). p values are indicated in the graphs by symbols with * representing p&lt;0.05, ** representing p&lt;0.01, *** representing p&lt;0.001. Exact p values are given in the Figure legends.</p><p>The number of replicates used for the study was determined by prior experience and did not result from a formal sample size estimation. The ‘n’ indicated for each figure in the figure legend represents the number of animals (biological replicates).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft, Validation, Visualization, Writing – review and editing, Methodology</p></fn><fn fn-type="con" id="con2"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Resources, Supervision, Funding acquisition, Validation, Methodology, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Resources, Supervision, Funding acquisition, Validation, Methodology, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Data curation, Formal analysis, Supervision, Investigation, Methodology, Writing – original draft, Project administration</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal experiments were carried out in accordance with the European Communities Council Directive of November 24, 1986 (86/609/EEC) and approved by the Landesdirektion Dresden, Germany.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-81943-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Data used to generate graphs.</title></caption><media xlink:href="elife-81943-data1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Min Ae Lee-Kirsch (TU Dresden) for very helpful comments on the manuscript and Andrea Kempe, Annett Böhme, Katrin Höhne and Kristin Wogan for excellent technical assistance. Funding This work was supported by the German Research Foundation (DFG) SFB TRR237, B18 and FA-658-3-1.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JP</given-names></name><name><surname>Walker</surname><given-names>DE</given-names></name><name><surname>Goldstein</surname><given-names>JM</given-names></name><name><surname>de Laat</surname><given-names>R</given-names></name><name><surname>Banducci</surname><given-names>K</given-names></name><name><surname>Caccavello</surname><given-names>RJ</given-names></name><name><surname>Barbour</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Kling</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Diep</surname><given-names>L</given-names></name><name><surname>Keim</surname><given-names>PS</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Chataway</surname><given-names>T</given-names></name><name><surname>Schlossmacher</surname><given-names>MG</given-names></name><name><surname>Seubert</surname><given-names>P</given-names></name><name><surname>Schenk</surname><given-names>D</given-names></name><name><surname>Sinha</surname><given-names>S</given-names></name><name><surname>Gai</surname><given-names>WP</given-names></name><name><surname>Chilcote</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>29739</fpage><lpage>29752</lpage><pub-id pub-id-type="doi">10.1074/jbc.M600933200</pub-id><pub-id pub-id-type="pmid">16847063</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balka</surname><given-names>KR</given-names></name><name><surname>Louis</surname><given-names>C</given-names></name><name><surname>Saunders</surname><given-names>TL</given-names></name><name><surname>Smith</surname><given-names>AM</given-names></name><name><surname>Calleja</surname><given-names>DJ</given-names></name><name><surname>D’Silva</surname><given-names>DB</given-names></name><name><surname>Moghaddas</surname><given-names>F</given-names></name><name><surname>Tailler</surname><given-names>M</given-names></name><name><surname>Lawlor</surname><given-names>KE</given-names></name><name><surname>Zhan</surname><given-names>Y</given-names></name><name><surname>Burns</surname><given-names>CJ</given-names></name><name><surname>Wicks</surname><given-names>IP</given-names></name><name><surname>Miner</surname><given-names>JJ</given-names></name><name><surname>Kile</surname><given-names>BT</given-names></name><name><surname>Masters</surname><given-names>SL</given-names></name><name><surname>De Nardo</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tbk1 and IKKε act redundantly to mediate STING-induced NF-κB responses in myeloid cells</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107492</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.03.056</pub-id><pub-id pub-id-type="pmid">32268090</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balka</surname><given-names>K.R</given-names></name><name><surname>De Nardo</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Molecular and spatial mechanisms governing sting signalling</article-title><source>The FEBS Journal</source><volume>288</volume><fpage>5504</fpage><lpage>5529</lpage><pub-id pub-id-type="doi">10.1111/febs.15640</pub-id><pub-id pub-id-type="pmid">33237620</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bantle</surname><given-names>CM</given-names></name><name><surname>Rocha</surname><given-names>SM</given-names></name><name><surname>French</surname><given-names>CT</given-names></name><name><surname>Phillips</surname><given-names>AT</given-names></name><name><surname>Tran</surname><given-names>K</given-names></name><name><surname>Olson</surname><given-names>KE</given-names></name><name><surname>Bass</surname><given-names>TA</given-names></name><name><surname>Aboellail</surname><given-names>T</given-names></name><name><surname>Smeyne</surname><given-names>RJ</given-names></name><name><surname>Tjalkens</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis</article-title><source>Experimental Neurology</source><volume>346</volume><elocation-id>113845</elocation-id><pub-id pub-id-type="doi">10.1016/j.expneurol.2021.113845</pub-id><pub-id pub-id-type="pmid">34454938</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauernfeind</surname><given-names>FG</given-names></name><name><surname>Horvath</surname><given-names>G</given-names></name><name><surname>Stutz</surname><given-names>A</given-names></name><name><surname>Alnemri</surname><given-names>ES</given-names></name><name><surname>MacDonald</surname><given-names>K</given-names></name><name><surname>Speert</surname><given-names>D</given-names></name><name><surname>Fernandes-Alnemri</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Monks</surname><given-names>BG</given-names></name><name><surname>Fitzgerald</surname><given-names>KA</given-names></name><name><surname>Hornung</surname><given-names>V</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cutting edge: NF-kappab activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression</article-title><source>Journal of Immunology</source><volume>183</volume><fpage>787</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0901363</pub-id><pub-id pub-id-type="pmid">19570822</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bentea</surname><given-names>E</given-names></name><name><surname>Van der Perren</surname><given-names>A</given-names></name><name><surname>Van Liefferinge</surname><given-names>J</given-names></name><name><surname>El Arfani</surname><given-names>A</given-names></name><name><surname>Albertini</surname><given-names>G</given-names></name><name><surname>Demuyser</surname><given-names>T</given-names></name><name><surname>Merckx</surname><given-names>E</given-names></name><name><surname>Michotte</surname><given-names>Y</given-names></name><name><surname>Smolders</surname><given-names>I</given-names></name><name><surname>Baekelandt</surname><given-names>V</given-names></name><name><surname>Massie</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of ser129 phosphorylated α-synuclein</article-title><source>Frontiers in Behavioral Neuroscience</source><volume>9</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.3389/fnbeh.2015.00068</pub-id><pub-id pub-id-type="pmid">25873870</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bido</surname><given-names>S</given-names></name><name><surname>Muggeo</surname><given-names>S</given-names></name><name><surname>Massimino</surname><given-names>L</given-names></name><name><surname>Marzi</surname><given-names>MJ</given-names></name><name><surname>Giannelli</surname><given-names>SG</given-names></name><name><surname>Melacini</surname><given-names>E</given-names></name><name><surname>Nannoni</surname><given-names>M</given-names></name><name><surname>Gambarè</surname><given-names>D</given-names></name><name><surname>Bellini</surname><given-names>E</given-names></name><name><surname>Ordazzo</surname><given-names>G</given-names></name><name><surname>Rossi</surname><given-names>G</given-names></name><name><surname>Maffezzini</surname><given-names>C</given-names></name><name><surname>Iannelli</surname><given-names>A</given-names></name><name><surname>Luoni</surname><given-names>M</given-names></name><name><surname>Bagicaluppi</surname><given-names>M</given-names></name><name><surname>Gregori</surname><given-names>S</given-names></name><name><surname>Nicassio</surname><given-names>F</given-names></name><name><surname>Broccoli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity</article-title><source>Nat Commun</source><volume>121</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1038/s41467-021-26519-x</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broz</surname><given-names>P</given-names></name><name><surname>Dixit</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Inflammasomes: mechanism of assembly, regulation and signalling</article-title><source>Nat Rev Immunol</source><volume>16</volume><fpage>407</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.58</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>K</given-names></name><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Banerjee</surname><given-names>R</given-names></name><name><surname>Choudhury</surname><given-names>S</given-names></name><name><surname>Mondal</surname><given-names>B</given-names></name><name><surname>Halder</surname><given-names>S</given-names></name><name><surname>Basu</surname><given-names>P</given-names></name><name><surname>Shubham</surname><given-names>S</given-names></name><name><surname>Dey</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Inflammasome and α-synuclein in parkinson’s disease: A cross-sectional study</article-title><source>Journal of Neuroimmunology</source><volume>338</volume><elocation-id>577089</elocation-id><pub-id pub-id-type="doi">10.1016/j.jneuroim.2019.577089</pub-id><pub-id pub-id-type="pmid">31704453</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing</article-title><source>Nature Immunology</source><volume>17</volume><fpage>1142</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1038/ni.3558</pub-id><pub-id pub-id-type="pmid">27648547</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Lai</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Bao</surname><given-names>WD</given-names></name><name><surname>Yang</surname><given-names>LN</given-names></name><name><surname>Xu</surname><given-names>PP</given-names></name><name><surname>Zhu</surname><given-names>LQ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>CGAS-STING-mediated IFN-I response in host defense and neuro-inflammatory diseases</article-title><source>Curr Neuropharmacol</source><volume>19</volume><fpage>362</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.2174/1570159X19666210924110144</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collart</surname><given-names>MA</given-names></name><name><surname>Baeuerle</surname><given-names>P</given-names></name><name><surname>Vassalli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B</article-title><source>Molecular and Cellular Biology</source><volume>10</volume><fpage>1498</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1128/mcb.10.4.1498-1506.1990</pub-id><pub-id pub-id-type="pmid">2181276</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crow</surname><given-names>YJ</given-names></name><name><surname>Casanova</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>STING-associated vasculopathy with onset in infancy -- a new interferonopathy</article-title><source>The New England Journal of Medicine</source><volume>371</volume><fpage>568</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1056/NEJMe1407246</pub-id><pub-id pub-id-type="pmid">25029336</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Sreevatsan</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Song</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Barrow</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mycobacterium bovis induces endoplasmic reticulum stress mediated-apoptosis by activating IRF3 in a murine macrophage cell line</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>6</volume><elocation-id>182</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2016.00182</pub-id><pub-id pub-id-type="pmid">28018864</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decout</surname><given-names>A</given-names></name><name><surname>Katz</surname><given-names>JD</given-names></name><name><surname>Venkatraman</surname><given-names>S</given-names></name><name><surname>Ablasser</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The cGAS-STING pathway as a therapeutic target in inflammatory diseases</article-title><source>Nature Reviews. Immunology</source><volume>21</volume><fpage>548</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1038/s41577-021-00524-z</pub-id><pub-id pub-id-type="pmid">33833439</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebrahimi-Fakhari</surname><given-names>D</given-names></name><name><surname>Cantuti-Castelvetri</surname><given-names>I</given-names></name><name><surname>Fan</surname><given-names>Z</given-names></name><name><surname>Rockenstein</surname><given-names>E</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>McLean</surname><given-names>PJ</given-names></name><name><surname>Unni</surname><given-names>VK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>14508</fpage><lpage>14520</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1560-11.2011</pub-id><pub-id pub-id-type="pmid">21994367</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ejlerskov</surname><given-names>P</given-names></name><name><surname>Hultberg</surname><given-names>JG</given-names></name><name><surname>Wang</surname><given-names>JY</given-names></name><name><surname>Carlsson</surname><given-names>R</given-names></name><name><surname>Ambjørn</surname><given-names>M</given-names></name><name><surname>Kuss</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Porcu</surname><given-names>G</given-names></name><name><surname>Kolkova</surname><given-names>K</given-names></name><name><surname>Friis Rundsten</surname><given-names>C</given-names></name><name><surname>Ruscher</surname><given-names>K</given-names></name><name><surname>Pakkenberg</surname><given-names>B</given-names></name><name><surname>Goldmann</surname><given-names>T</given-names></name><name><surname>Loreth</surname><given-names>D</given-names></name><name><surname>Prinz</surname><given-names>M</given-names></name><name><surname>Rubinsztein</surname><given-names>DC</given-names></name><name><surname>Issazadeh-Navikas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Lack of neuronal IFN-β-IFNAR causes Lewy body- and Parkinson’s disease-like dementia</article-title><source>Cell</source><volume>163</volume><fpage>324</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.08.069</pub-id><pub-id pub-id-type="pmid">26451483</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falkenburger</surname><given-names>BH</given-names></name><name><surname>Barstow</surname><given-names>KL</given-names></name><name><surname>Mintz</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Dendrodendritic inhibition through reversal of dopamine transport</article-title><source>Science</source><volume>293</volume><fpage>2465</fpage><lpage>2470</lpage><pub-id pub-id-type="doi">10.1126/science.1060645</pub-id><pub-id pub-id-type="pmid">11577238</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freischmidt</surname><given-names>A</given-names></name><name><surname>Wieland</surname><given-names>T</given-names></name><name><surname>Richter</surname><given-names>B</given-names></name><name><surname>Ruf</surname><given-names>W</given-names></name><name><surname>Schaeffer</surname><given-names>V</given-names></name><name><surname>Müller</surname><given-names>K</given-names></name><name><surname>Marroquin</surname><given-names>N</given-names></name><name><surname>Nordin</surname><given-names>F</given-names></name><name><surname>Hübers</surname><given-names>A</given-names></name><name><surname>Weydt</surname><given-names>P</given-names></name><name><surname>Pinto</surname><given-names>S</given-names></name><name><surname>Press</surname><given-names>R</given-names></name><name><surname>Millecamps</surname><given-names>S</given-names></name><name><surname>Molko</surname><given-names>N</given-names></name><name><surname>Bernard</surname><given-names>E</given-names></name><name><surname>Desnuelle</surname><given-names>C</given-names></name><name><surname>Soriani</surname><given-names>M-H</given-names></name><name><surname>Dorst</surname><given-names>J</given-names></name><name><surname>Graf</surname><given-names>E</given-names></name><name><surname>Nordström</surname><given-names>U</given-names></name><name><surname>Feiler</surname><given-names>MS</given-names></name><name><surname>Putz</surname><given-names>S</given-names></name><name><surname>Boeckers</surname><given-names>TM</given-names></name><name><surname>Meyer</surname><given-names>T</given-names></name><name><surname>Winkler</surname><given-names>AS</given-names></name><name><surname>Winkelman</surname><given-names>J</given-names></name><name><surname>de Carvalho</surname><given-names>M</given-names></name><name><surname>Thal</surname><given-names>DR</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name><name><surname>Brännström</surname><given-names>T</given-names></name><name><surname>Volk</surname><given-names>AE</given-names></name><name><surname>Kursula</surname><given-names>P</given-names></name><name><surname>Danzer</surname><given-names>KM</given-names></name><name><surname>Lichtner</surname><given-names>P</given-names></name><name><surname>Dikic</surname><given-names>I</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>Ludolph</surname><given-names>AC</given-names></name><name><surname>Strom</surname><given-names>TM</given-names></name><name><surname>Andersen</surname><given-names>PM</given-names></name><name><surname>Weishaupt</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>631</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1038/nn.4000</pub-id><pub-id pub-id-type="pmid">25803835</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frémond</surname><given-names>ML</given-names></name><name><surname>Hadchouel</surname><given-names>A</given-names></name><name><surname>Berteloot</surname><given-names>L</given-names></name><name><surname>Melki</surname><given-names>I</given-names></name><name><surname>Bresson</surname><given-names>V</given-names></name><name><surname>Barnabei</surname><given-names>L</given-names></name><name><surname>Jeremiah</surname><given-names>N</given-names></name><name><surname>Belot</surname><given-names>A</given-names></name><name><surname>Bondet</surname><given-names>V</given-names></name><name><surname>Brocq</surname><given-names>O</given-names></name><name><surname>Chan</surname><given-names>D</given-names></name><name><surname>Dagher</surname><given-names>R</given-names></name><name><surname>Dubus</surname><given-names>JC</given-names></name><name><surname>Duffy</surname><given-names>D</given-names></name><name><surname>Feuillet-Soummer</surname><given-names>S</given-names></name><name><surname>Fusaro</surname><given-names>M</given-names></name><name><surname>Gattorno</surname><given-names>M</given-names></name><name><surname>Insalaco</surname><given-names>A</given-names></name><name><surname>Jeziorski</surname><given-names>E</given-names></name><name><surname>Kitabayashi</surname><given-names>N</given-names></name><name><surname>Lopez-Corbeto</surname><given-names>M</given-names></name><name><surname>Mazingue</surname><given-names>F</given-names></name><name><surname>Morren</surname><given-names>MA</given-names></name><name><surname>Rice</surname><given-names>GI</given-names></name><name><surname>Rivière</surname><given-names>JG</given-names></name><name><surname>Seabra</surname><given-names>L</given-names></name><name><surname>Sirvente</surname><given-names>J</given-names></name><name><surname>Soler-Palacin</surname><given-names>P</given-names></name><name><surname>Stremler-Le Bel</surname><given-names>N</given-names></name><name><surname>Thouvenin</surname><given-names>G</given-names></name><name><surname>Thumerelle</surname><given-names>C</given-names></name><name><surname>Van Aerde</surname><given-names>E</given-names></name><name><surname>Volpi</surname><given-names>S</given-names></name><name><surname>Willcocks</surname><given-names>S</given-names></name><name><surname>Wouters</surname><given-names>C</given-names></name><name><surname>Breton</surname><given-names>S</given-names></name><name><surname>Molina</surname><given-names>T</given-names></name><name><surname>Bader-Meunier</surname><given-names>B</given-names></name><name><surname>Moshous</surname><given-names>D</given-names></name><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Blanche</surname><given-names>S</given-names></name><name><surname>Rieux-Laucat</surname><given-names>F</given-names></name><name><surname>Crow</surname><given-names>YJ</given-names></name><name><surname>Neven</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients</article-title><source>The Journal of Allergy and Clinical Immunology. In Practice</source><volume>9</volume><fpage>803</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1016/j.jaip.2020.11.007</pub-id><pub-id pub-id-type="pmid">33217613</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froula</surname><given-names>JM</given-names></name><name><surname>Castellana-Cruz</surname><given-names>M</given-names></name><name><surname>Anabtawi</surname><given-names>NM</given-names></name><name><surname>Camino</surname><given-names>JD</given-names></name><name><surname>Chen</surname><given-names>SW</given-names></name><name><surname>Thrasher</surname><given-names>DR</given-names></name><name><surname>Freire</surname><given-names>J</given-names></name><name><surname>Yazdi</surname><given-names>AA</given-names></name><name><surname>Fleming</surname><given-names>S</given-names></name><name><surname>Dobson</surname><given-names>CM</given-names></name><name><surname>Kumita</surname><given-names>JR</given-names></name><name><surname>Cremades</surname><given-names>N</given-names></name><name><surname>Volpicelli-Daley</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Defining α-synuclein species responsible for Parkinson’s disease phenotypes in mice</article-title><source>The Journal of Biological Chemistry</source><volume>294</volume><fpage>10392</fpage><lpage>10406</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA119.007743</pub-id><pub-id pub-id-type="pmid">31142553</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname><given-names>H</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Dohmae</surname><given-names>N</given-names></name><name><surname>Kawashima</surname><given-names>A</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name><name><surname>Goldberg</surname><given-names>MS</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Takio</surname><given-names>K</given-names></name><name><surname>Iwatsubo</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Alpha-Synuclein is phosphorylated in synucleinopathy lesions</article-title><source>Nature Cell Biology</source><volume>4</volume><fpage>160</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1038/ncb748</pub-id><pub-id pub-id-type="pmid">11813001</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaidt</surname><given-names>MM</given-names></name><name><surname>Ebert</surname><given-names>TS</given-names></name><name><surname>Chauhan</surname><given-names>D</given-names></name><name><surname>Ramshorn</surname><given-names>K</given-names></name><name><surname>Pinci</surname><given-names>F</given-names></name><name><surname>Zuber</surname><given-names>S</given-names></name><name><surname>O’Duill</surname><given-names>F</given-names></name><name><surname>Schmid-Burgk</surname><given-names>JL</given-names></name><name><surname>Hoss</surname><given-names>F</given-names></name><name><surname>Buhmann</surname><given-names>R</given-names></name><name><surname>Wittmann</surname><given-names>G</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name><name><surname>Subklewe</surname><given-names>M</given-names></name><name><surname>Hornung</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3</article-title><source>Cell</source><volume>171</volume><fpage>1110</fpage><lpage>1124</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.09.039</pub-id><pub-id pub-id-type="pmid">29033128</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gal-Ben-Ari</surname><given-names>S</given-names></name><name><surname>Barrera</surname><given-names>I</given-names></name><name><surname>Ehrlich</surname><given-names>M</given-names></name><name><surname>Rosenblum</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pkr: a kinase to remember</article-title><source>Frontiers in Molecular Neuroscience</source><volume>11</volume><elocation-id>480</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2018.00480</pub-id><pub-id pub-id-type="pmid">30686999</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Szego</surname><given-names>ÉM</given-names></name><name><surname>Leonov</surname><given-names>A</given-names></name><name><surname>Benito</surname><given-names>E</given-names></name><name><surname>Becker</surname><given-names>S</given-names></name><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Zweckstetter</surname><given-names>M</given-names></name><name><surname>Outeiro</surname><given-names>T</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Translocator protein ligand protects against neurodegeneration in the MPTP mouse model of parkinsonism</article-title><source>The Journal of Neuroscience</source><volume>39</volume><fpage>3752</fpage><lpage>3769</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2070-18.2019</pub-id><pub-id pub-id-type="pmid">30796158</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>JN</given-names></name><name><surname>Sanchez-Padilla</surname><given-names>J</given-names></name><name><surname>Wokosin</surname><given-names>D</given-names></name><name><surname>Kondapalli</surname><given-names>J</given-names></name><name><surname>Ilijic</surname><given-names>E</given-names></name><name><surname>Schumacker</surname><given-names>PT</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1</article-title><source>Nature</source><volume>468</volume><fpage>696</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1038/nature09536</pub-id><pub-id pub-id-type="pmid">21068725</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>S</given-names></name><name><surname>Janelidze</surname><given-names>S</given-names></name><name><surname>Surova</surname><given-names>Y</given-names></name><name><surname>Widner</surname><given-names>H</given-names></name><name><surname>Zetterberg</surname><given-names>H</given-names></name><name><surname>Hansson</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cerebrospinal fluid concentrations of inflammatory markers in parkinson’s disease and atypical parkinsonian disorders</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>13276</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-31517-z</pub-id><pub-id pub-id-type="pmid">30185816</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harms</surname><given-names>AS</given-names></name><name><surname>Kordower</surname><given-names>JH</given-names></name><name><surname>Sette</surname><given-names>A</given-names></name><name><surname>Lindestam Arlehamn</surname><given-names>CS</given-names></name><name><surname>Sulzer</surname><given-names>D</given-names></name><name><surname>Mach</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Inflammation in experimental models of α-synucleinopathies</article-title><source>Movement Disorders</source><volume>36</volume><fpage>37</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1002/mds.28264</pub-id><pub-id pub-id-type="pmid">33009855</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heneka</surname><given-names>MT</given-names></name><name><surname>McManus</surname><given-names>RM</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inflammasome signalling in brain function and neurodegenerative disease</article-title><source>Nature Reviews. Neuroscience</source><volume>19</volume><fpage>610</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1038/s41583-018-0055-7</pub-id><pub-id pub-id-type="pmid">30206330</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinkle</surname><given-names>JT</given-names></name><name><surname>Patel</surname><given-names>J</given-names></name><name><surname>Panicker</surname><given-names>N</given-names></name><name><surname>Karuppagounder</surname><given-names>SS</given-names></name><name><surname>Biswas</surname><given-names>D</given-names></name><name><surname>Belingon</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Brahmachari</surname><given-names>S</given-names></name><name><surname>Pletnikova</surname><given-names>O</given-names></name><name><surname>Troncoso</surname><given-names>JC</given-names></name><name><surname>Dawson</surname><given-names>VL</given-names></name><name><surname>Dawson</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Sting mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy</article-title><source>PNAS</source><volume>119</volume><elocation-id>e2118819119</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2118819119</pub-id><pub-id pub-id-type="pmid">35394877</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>EC</given-names></name><name><surname>Standaert</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Ten unsolved questions about neuroinflammation in Parkinson’s disease</article-title><source>Movement Disorders</source><volume>36</volume><fpage>16</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1002/mds.28075</pub-id><pub-id pub-id-type="pmid">32357266</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiscott</surname><given-names>J</given-names></name><name><surname>Marois</surname><given-names>J</given-names></name><name><surname>Garoufalis</surname><given-names>J</given-names></name><name><surname>D’Addario</surname><given-names>M</given-names></name><name><surname>Roulston</surname><given-names>A</given-names></name><name><surname>Kwan</surname><given-names>I</given-names></name><name><surname>Pepin</surname><given-names>N</given-names></name><name><surname>Lacoste</surname><given-names>J</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>Bensi</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop</article-title><source>Molecular and Cellular Biology</source><volume>13</volume><fpage>6231</fpage><lpage>6240</lpage><pub-id pub-id-type="doi">10.1128/mcb.13.10.6231-6240.1993</pub-id><pub-id pub-id-type="pmid">8413223</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopfner</surname><given-names>KP</given-names></name><name><surname>Hornung</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Molecular mechanisms and cellular functions of cGAS-STING signalling</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>21</volume><fpage>501</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-0244-x</pub-id><pub-id pub-id-type="pmid">32424334</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaraman</surname><given-names>A</given-names></name><name><surname>Htike</surname><given-names>TT</given-names></name><name><surname>James</surname><given-names>R</given-names></name><name><surname>Picon</surname><given-names>C</given-names></name><name><surname>Reynolds</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Tnf-mediated neuroinflammation is linked to neuronal necroptosis in alzheimer’s disease hippocampus</article-title><source>Acta Neuropathologica Communications</source><volume>9</volume><elocation-id>159</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-021-01264-w</pub-id><pub-id pub-id-type="pmid">34625123</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffries</surname><given-names>AM</given-names></name><name><surname>Marriott</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human microglia and astrocytes express cGAS-STING viral sensing components</article-title><source>Neuroscience Letters</source><volume>658</volume><fpage>53</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2017.08.039</pub-id><pub-id pub-id-type="pmid">28830822</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keren-Shaul</surname><given-names>H</given-names></name><name><surname>Spinrad</surname><given-names>A</given-names></name><name><surname>Weiner</surname><given-names>A</given-names></name><name><surname>Matcovitch-Natan</surname><given-names>O</given-names></name><name><surname>Dvir-Szternfeld</surname><given-names>R</given-names></name><name><surname>Ulland</surname><given-names>TK</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Baruch</surname><given-names>K</given-names></name><name><surname>Lara-Astaiso</surname><given-names>D</given-names></name><name><surname>Toth</surname><given-names>B</given-names></name><name><surname>Itzkovitz</surname><given-names>S</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>M</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A unique microglia type associated with restricting development of Alzheimer’s disease</article-title><source>Cell</source><volume>169</volume><fpage>1276</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.05.018</pub-id><pub-id pub-id-type="pmid">28602351</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komnig</surname><given-names>D</given-names></name><name><surname>Dagli</surname><given-names>TC</given-names></name><name><surname>Habib</surname><given-names>P</given-names></name><name><surname>Zeyen</surname><given-names>T</given-names></name><name><surname>Schulz</surname><given-names>JB</given-names></name><name><surname>Falkenburger</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson’s disease and does not lead to a sustainable increase of brain-derived neurotrophic factor</article-title><source>Journal of Neurochemistry</source><volume>147</volume><fpage>678</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1111/jnc.14575</pub-id><pub-id pub-id-type="pmid">30152864</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovács</surname><given-names>B</given-names></name><name><surname>Vajda</surname><given-names>E</given-names></name><name><surname>Nagy</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Regulatory effects and interactions of the Wnt and OPG-RANKL-RANK signaling at the bone-cartilage interface in osteoarthritis</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>E4653</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20184653</pub-id><pub-id pub-id-type="pmid">31546898</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>HS</given-names></name><name><surname>Koh</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes</article-title><source>Translational Neurodegeneration</source><volume>9</volume><elocation-id>42</elocation-id><pub-id pub-id-type="doi">10.1186/s40035-020-00221-2</pub-id><pub-id pub-id-type="pmid">33239064</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The cgas-cgamp-sting pathway connects DNA damage to inflammation, senescence, and cancer</article-title><source>The Journal of Experimental Medicine</source><volume>215</volume><fpage>1287</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.1084/jem.20180139</pub-id><pub-id pub-id-type="pmid">29622565</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>ZD</given-names></name><name><surname>Potter</surname><given-names>ED</given-names></name><name><surname>Lipton</surname><given-names>JW</given-names></name><name><surname>Carvey</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines</article-title><source>Experimental Neurology</source><volume>149</volume><fpage>411</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1006/exnr.1998.6715</pub-id><pub-id pub-id-type="pmid">9500954</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Jesus</surname><given-names>AA</given-names></name><name><surname>Marrero</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Ramsey</surname><given-names>SE</given-names></name><name><surname>Sanchez</surname><given-names>GAM</given-names></name><name><surname>Tenbrock</surname><given-names>K</given-names></name><name><surname>Wittkowski</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>OY</given-names></name><name><surname>Kuehn</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>C-CR</given-names></name><name><surname>DiMattia</surname><given-names>MA</given-names></name><name><surname>Cowen</surname><given-names>EW</given-names></name><name><surname>Gonzalez</surname><given-names>B</given-names></name><name><surname>Palmer</surname><given-names>I</given-names></name><name><surname>DiGiovanna</surname><given-names>JJ</given-names></name><name><surname>Biancotto</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Tsai</surname><given-names>WL</given-names></name><name><surname>Trier</surname><given-names>AM</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Stone</surname><given-names>DL</given-names></name><name><surname>Hill</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>St Hilaire</surname><given-names>C</given-names></name><name><surname>Gurprasad</surname><given-names>S</given-names></name><name><surname>Plass</surname><given-names>N</given-names></name><name><surname>Chapelle</surname><given-names>D</given-names></name><name><surname>Horkayne-Szakaly</surname><given-names>I</given-names></name><name><surname>Foell</surname><given-names>D</given-names></name><name><surname>Barysenka</surname><given-names>A</given-names></name><name><surname>Candotti</surname><given-names>F</given-names></name><name><surname>Holland</surname><given-names>SM</given-names></name><name><surname>Hughes</surname><given-names>JD</given-names></name><name><surname>Mehmet</surname><given-names>H</given-names></name><name><surname>Issekutz</surname><given-names>AC</given-names></name><name><surname>Raffeld</surname><given-names>M</given-names></name><name><surname>McElwee</surname><given-names>J</given-names></name><name><surname>Fontana</surname><given-names>JR</given-names></name><name><surname>Minniti</surname><given-names>CP</given-names></name><name><surname>Moir</surname><given-names>S</given-names></name><name><surname>Kastner</surname><given-names>DL</given-names></name><name><surname>Gadina</surname><given-names>M</given-names></name><name><surname>Steven</surname><given-names>AC</given-names></name><name><surname>Wingfield</surname><given-names>PT</given-names></name><name><surname>Brooks</surname><given-names>SR</given-names></name><name><surname>Rosenzweig</surname><given-names>SD</given-names></name><name><surname>Fleisher</surname><given-names>TA</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Boehm</surname><given-names>M</given-names></name><name><surname>Paller</surname><given-names>AS</given-names></name><name><surname>Goldbach-Mansky</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Activated sting in a vascular and pulmonary syndrome</article-title><source>The New England Journal of Medicine</source><volume>371</volume><fpage>507</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1312625</pub-id><pub-id pub-id-type="pmid">25029335</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>WL</given-names></name><name><surname>Yang</surname><given-names>HC</given-names></name><name><surname>Hsu</surname><given-names>CS</given-names></name><name><surname>Wang</surname><given-names>CC</given-names></name><name><surname>Wang</surname><given-names>TS</given-names></name><name><surname>Kao</surname><given-names>JH</given-names></name><name><surname>Chen</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mtor pathway</article-title><source>PNAS</source><volume>113</volume><fpage>14799</fpage><lpage>14804</lpage><pub-id pub-id-type="doi">10.1073/pnas.1618517114</pub-id><pub-id pub-id-type="pmid">27930338</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Gordesky-Gold</surname><given-names>B</given-names></name><name><surname>Leney-Greene</surname><given-names>M</given-names></name><name><surname>Weinbren</surname><given-names>NL</given-names></name><name><surname>Tudor</surname><given-names>M</given-names></name><name><surname>Cherry</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inflammation-Induced, STING-dependent autophagy restricts Zika virus infection in the <italic>Drosophila</italic> brain</article-title><source>Cell Host &amp; Microbe</source><volume>24</volume><fpage>57</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2018.05.022</pub-id><pub-id pub-id-type="pmid">29934091</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luksch</surname><given-names>H</given-names></name><name><surname>Stinson</surname><given-names>WA</given-names></name><name><surname>Platt</surname><given-names>DJ</given-names></name><name><surname>Qian</surname><given-names>W</given-names></name><name><surname>Kalugotla</surname><given-names>G</given-names></name><name><surname>Miner</surname><given-names>CA</given-names></name><name><surname>Bennion</surname><given-names>BG</given-names></name><name><surname>Gerbaulet</surname><given-names>A</given-names></name><name><surname>Rösen-Wolff</surname><given-names>A</given-names></name><name><surname>Miner</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>STING-associated lung disease in mice relies on T cells but not type I interferon</article-title><source>The Journal of Allergy and Clinical Immunology</source><volume>144</volume><fpage>254</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2019.01.044</pub-id><pub-id pub-id-type="pmid">30772497</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magalhaes</surname><given-names>J</given-names></name><name><surname>Tresse</surname><given-names>E</given-names></name><name><surname>Ejlerskov</surname><given-names>P</given-names></name><name><surname>Hu</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Marin</surname><given-names>A</given-names></name><name><surname>Montalant</surname><given-names>A</given-names></name><name><surname>Satriano</surname><given-names>L</given-names></name><name><surname>Rundsten</surname><given-names>CF</given-names></name><name><surname>Carlsen</surname><given-names>EMM</given-names></name><name><surname>Rydbirk</surname><given-names>R</given-names></name><name><surname>Sharifi-Zarchi</surname><given-names>A</given-names></name><name><surname>Andersen</surname><given-names>JB</given-names></name><name><surname>Aznar</surname><given-names>S</given-names></name><name><surname>Brudek</surname><given-names>T</given-names></name><name><surname>Khodosevich</surname><given-names>K</given-names></name><name><surname>Prinz</surname><given-names>M</given-names></name><name><surname>Perrier</surname><given-names>JFM</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Gasser</surname><given-names>T</given-names></name><name><surname>Issazadeh-Navikas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>PIAS2-mediated blockade of IFN-β signaling: a basis for sporadic Parkinson disease dementia</article-title><source>Molecular Psychiatry</source><volume>26</volume><fpage>6083</fpage><lpage>6099</lpage><pub-id pub-id-type="doi">10.1038/s41380-021-01207-w</pub-id><pub-id pub-id-type="pmid">34234281</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollenhauer</surname><given-names>B</given-names></name><name><surname>Zimmermann</surname><given-names>J</given-names></name><name><surname>Sixel-Döring</surname><given-names>F</given-names></name><name><surname>Focke</surname><given-names>NK</given-names></name><name><surname>Wicke</surname><given-names>T</given-names></name><name><surname>Ebentheuer</surname><given-names>J</given-names></name><name><surname>Schaumburg</surname><given-names>M</given-names></name><name><surname>Lang</surname><given-names>E</given-names></name><name><surname>Friede</surname><given-names>T</given-names></name><name><surname>Trenkwalder</surname><given-names>C</given-names></name><collab>DeNoPa Study Group</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Baseline predictors for progression 4 years after Parkinson’s disease diagnosis in the de novo Parkinson cohort (denopa)</article-title><source>Movement Disorders</source><volume>34</volume><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1002/mds.27492</pub-id><pub-id pub-id-type="pmid">30468694</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moretti</surname><given-names>J</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Bozec</surname><given-names>D</given-names></name><name><surname>Martinez</surname><given-names>J</given-names></name><name><surname>Chapman</surname><given-names>JR</given-names></name><name><surname>Ueberheide</surname><given-names>B</given-names></name><name><surname>Lamming</surname><given-names>DW</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name><name><surname>Horng</surname><given-names>T</given-names></name><name><surname>Yeretssian</surname><given-names>G</given-names></name><name><surname>Green</surname><given-names>DR</given-names></name><name><surname>Blander</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sting senses microbial viability to orchestrate stress-mediated autophagy of the endoplasmic reticulum</article-title><source>Cell</source><volume>171</volume><fpage>809</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.09.034</pub-id><pub-id pub-id-type="pmid">29056340</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motwani</surname><given-names>M</given-names></name><name><surname>Pesiridis</surname><given-names>S</given-names></name><name><surname>Fitzgerald</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dna sensing by the cGAS-STING pathway in health and disease</article-title><source>Nature Reviews. Genetics</source><volume>20</volume><fpage>657</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1038/s41576-019-0151-1</pub-id><pub-id pub-id-type="pmid">31358977</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murthy</surname><given-names>AMV</given-names></name><name><surname>Robinson</surname><given-names>N</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Crosstalk between cGAS-STING signaling and cell death</article-title><source>Cell Death and Differentiation</source><volume>27</volume><fpage>2989</fpage><lpage>3003</lpage><pub-id pub-id-type="doi">10.1038/s41418-020-00624-8</pub-id><pub-id pub-id-type="pmid">32948836</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>M</given-names></name><name><surname>Kahle</surname><given-names>PJ</given-names></name><name><surname>Giasson</surname><given-names>BI</given-names></name><name><surname>Ozmen</surname><given-names>L</given-names></name><name><surname>Borroni</surname><given-names>E</given-names></name><name><surname>Spooren</surname><given-names>W</given-names></name><name><surname>Müller</surname><given-names>V</given-names></name><name><surname>Odoy</surname><given-names>S</given-names></name><name><surname>Fujiwara</surname><given-names>H</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Iwatsubo</surname><given-names>T</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><name><surname>Kretzschmar</surname><given-names>HA</given-names></name><name><surname>Haass</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies</article-title><source>The Journal of Clinical Investigation</source><volume>110</volume><fpage>1429</fpage><lpage>1439</lpage><pub-id pub-id-type="doi">10.1172/JCI15777</pub-id><pub-id pub-id-type="pmid">12438441</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noguchi</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>N</given-names></name><name><surname>Kumazaki</surname><given-names>M</given-names></name><name><surname>Yasui</surname><given-names>Y</given-names></name><name><surname>Iwasaki</surname><given-names>J</given-names></name><name><surname>Naito</surname><given-names>S</given-names></name><name><surname>Akao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Socs7, a target gene of microrna-145, regulates interferon-β induction through STAT3 nuclear translocation in bladder cancer cells</article-title><source>Cell Death Dis</source><volume>4</volume><elocation-id>e482</elocation-id><pub-id pub-id-type="doi">10.1038/CDDIS.2013.11</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveras-Salvá</surname><given-names>M</given-names></name><name><surname>Van Der Perren</surname><given-names>A</given-names></name><name><surname>Casadei</surname><given-names>N</given-names></name><name><surname>Stroobants</surname><given-names>S</given-names></name><name><surname>Nuber</surname><given-names>S</given-names></name><name><surname>D’Hooge</surname><given-names>R</given-names></name><name><surname>Van Den Haute</surname><given-names>C</given-names></name><name><surname>Baekelandt</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>RAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration</article-title><source>Mol Neurodegener</source><volume>8</volume><elocation-id>44</elocation-id><pub-id pub-id-type="doi">10.1186/1750-1326-8-44</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>LK</given-names></name><name><surname>Cairns</surname><given-names>AG</given-names></name><name><surname>Ådén</surname><given-names>J</given-names></name><name><surname>Moriarty</surname><given-names>N</given-names></name><name><surname>Cabre</surname><given-names>S</given-names></name><name><surname>Alamilla</surname><given-names>VR</given-names></name><name><surname>Almqvist</surname><given-names>F</given-names></name><name><surname>Dowd</surname><given-names>E</given-names></name><name><surname>McKernan</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Viral mimetic priming enhances α-synuclein-induced degeneration: implications for parkinson’s disease</article-title><source>Brain, Behavior, and Immunity</source><volume>80</volume><fpage>525</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2019.04.036</pub-id><pub-id pub-id-type="pmid">31029796</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orihuela</surname><given-names>R</given-names></name><name><surname>McPherson</surname><given-names>CA</given-names></name><name><surname>Harry</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Microglial M1/M2 polarization and metabolic states</article-title><source>British Journal of Pharmacology</source><volume>173</volume><fpage>649</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1111/bph.13139</pub-id><pub-id pub-id-type="pmid">25800044</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pais</surname><given-names>TF</given-names></name><name><surname>Szegő</surname><given-names>ÉM</given-names></name><name><surname>Marques</surname><given-names>O</given-names></name><name><surname>Miller-Fleming</surname><given-names>L</given-names></name><name><surname>Antas</surname><given-names>P</given-names></name><name><surname>Guerreiro</surname><given-names>P</given-names></name><name><surname>de Oliveira</surname><given-names>RM</given-names></name><name><surname>Kasapoglu</surname><given-names>B</given-names></name><name><surname>Outeiro</surname><given-names>TF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation</article-title><source>The EMBO Journal</source><volume>32</volume><fpage>2603</fpage><lpage>2616</lpage><pub-id pub-id-type="doi">10.1038/emboj.2013.200</pub-id><pub-id pub-id-type="pmid">24013120</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>BD</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name><name><surname>Bohr</surname><given-names>VA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Signaling by cgas-sting in neurodegeneration, neuroinflammation, and aging</article-title><source>Trends in Neurosciences</source><volume>44</volume><fpage>83</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2020.10.008</pub-id><pub-id pub-id-type="pmid">33187730</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname><given-names>G</given-names></name><name><surname>Franklin</surname><given-names>KBJ.</given-names></name></person-group><year iso-8601-date="2001">2001</year><source>Paxinos and Franklin’s the Mouse Brain in Stereotaxic Coordinates</source><publisher-name>Academic Press</publisher-name></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrasek</surname><given-names>J</given-names></name><name><surname>Iracheta-Vellve</surname><given-names>A</given-names></name><name><surname>Csak</surname><given-names>T</given-names></name><name><surname>Satishchandran</surname><given-names>A</given-names></name><name><surname>Kodys</surname><given-names>K</given-names></name><name><surname>Kurt-Jones</surname><given-names>EA</given-names></name><name><surname>Fitzgerald</surname><given-names>KA</given-names></name><name><surname>Szabo</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease</article-title><source>PNAS</source><volume>110</volume><fpage>16544</fpage><lpage>16549</lpage><pub-id pub-id-type="doi">10.1073/pnas.1308331110</pub-id><pub-id pub-id-type="pmid">24052526</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2020">2020</year><data-title>R: A language and environment for statistical computing</data-title><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reimer</surname><given-names>L</given-names></name><name><surname>Vesterager</surname><given-names>LB</given-names></name><name><surname>Betzer</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Nielsen</surname><given-names>LD</given-names></name><name><surname>Kofoed</surname><given-names>RH</given-names></name><name><surname>Lassen</surname><given-names>LB</given-names></name><name><surname>Bølcho</surname><given-names>U</given-names></name><name><surname>Paludan</surname><given-names>SR</given-names></name><name><surname>Fog</surname><given-names>K</given-names></name><name><surname>Jensen</surname><given-names>PH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell death</article-title><source>Neurobiology of Disease</source><volume>115</volume><fpage>17</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2018.03.001</pub-id><pub-id pub-id-type="pmid">29501855</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinke</surname><given-names>S</given-names></name><name><surname>Linge</surname><given-names>M</given-names></name><name><surname>Diebner</surname><given-names>HH</given-names></name><name><surname>Luksch</surname><given-names>H</given-names></name><name><surname>Glage</surname><given-names>S</given-names></name><name><surname>Gocht</surname><given-names>A</given-names></name><name><surname>Robertson</surname><given-names>AAB</given-names></name><name><surname>Cooper</surname><given-names>MA</given-names></name><name><surname>Hofmann</surname><given-names>SR</given-names></name><name><surname>Naumann</surname><given-names>R</given-names></name><name><surname>Sarov</surname><given-names>M</given-names></name><name><surname>Behrendt</surname><given-names>R</given-names></name><name><surname>Roers</surname><given-names>A</given-names></name><name><surname>Pessler</surname><given-names>F</given-names></name><name><surname>Roesler</surname><given-names>J</given-names></name><name><surname>Rösen-Wolff</surname><given-names>A</given-names></name><name><surname>Winkler</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Non-Canonical caspase-1 signaling drives RIP2-dependent and TNF-α-mediated inflammation in vivo</article-title><source>Cell Reports</source><volume>30</volume><fpage>2501</fpage><lpage>2511</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.01.090</pub-id><pub-id pub-id-type="pmid">32101731</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Pallares</surname><given-names>J</given-names></name><name><surname>Guerra</surname><given-names>MJ</given-names></name><name><surname>Labandeira-Garcia</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Angiotensin II and interleukin-1 interact to increase generation of dopaminergic neurons from neurospheres of mesencephalic precursors</article-title><source>Brain Research. Developmental Brain Research</source><volume>158</volume><fpage>120</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.devbrainres.2005.06.009</pub-id><pub-id pub-id-type="pmid">16026856</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuel</surname><given-names>F</given-names></name><name><surname>Flavin</surname><given-names>WP</given-names></name><name><surname>Iqbal</surname><given-names>S</given-names></name><name><surname>Pacelli</surname><given-names>C</given-names></name><name><surname>Sri Renganathan</surname><given-names>SD</given-names></name><name><surname>Trudeau</surname><given-names>L-E</given-names></name><name><surname>Campbell</surname><given-names>EM</given-names></name><name><surname>Fraser</surname><given-names>PE</given-names></name><name><surname>Tandon</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Effects of serine 129 phosphorylation on α-synuclein aggregation, membrane association, and internalization</article-title><source>The Journal of Biological Chemistry</source><volume>291</volume><fpage>4374</fpage><lpage>4385</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.705095</pub-id><pub-id pub-id-type="pmid">26719332</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroder</surname><given-names>K</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The inflammasomes</article-title><source>Cell</source><volume>140</volume><fpage>821</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.01.040</pub-id><pub-id pub-id-type="pmid">20303873</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Shao</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Pyroptosis: gasdermin-mediated programmed necrotic cell death</article-title><source>Trends in Biochemical Sciences</source><volume>42</volume><fpage>245</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2016.10.004</pub-id><pub-id pub-id-type="pmid">27932073</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siedel</surname><given-names>H</given-names></name><name><surname>Roers</surname><given-names>A</given-names></name><name><surname>Rösen-Wolff</surname><given-names>A</given-names></name><name><surname>Luksch</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Type I interferon-independent T cell impairment in a tmem173 N153S/WT mouse model of sting associated vasculopathy with onset in infancy (SAVI)</article-title><source>Clinical Immunology</source><volume>216</volume><elocation-id>108466</elocation-id><pub-id pub-id-type="doi">10.1016/j.clim.2020.108466</pub-id><pub-id pub-id-type="pmid">32470544</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sliter</surname><given-names>DA</given-names></name><name><surname>Martinez</surname><given-names>J</given-names></name><name><surname>Hao</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>N</given-names></name><name><surname>Fischer</surname><given-names>TD</given-names></name><name><surname>Burman</surname><given-names>JL</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Narendra</surname><given-names>DP</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Borsche</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Parkin and pink1 mitigate sting-induced inflammation</article-title><source>Nature</source><volume>561</volume><fpage>258</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0448-9</pub-id><pub-id pub-id-type="pmid">30135585</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spandidos</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Seed</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification</article-title><source>Nucleic Acids Research</source><volume>38</volume><fpage>D792</fpage><lpage>D799</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp1005</pub-id><pub-id pub-id-type="pmid">19906719</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szego</surname><given-names>ÉM</given-names></name><name><surname>Gerhardt</surname><given-names>E</given-names></name><name><surname>Kermer</surname><given-names>P</given-names></name><name><surname>Schulz</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-dopa replacement in MPTP-treated mice</article-title><source>Neurobiology of Disease</source><volume>45</volume><fpage>591</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2011.09.017</pub-id><pub-id pub-id-type="pmid">22001606</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szegő</surname><given-names>ÉM</given-names></name><name><surname>Gerhardt</surname><given-names>E</given-names></name><name><surname>Outeiro</surname><given-names>TF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sirtuin 2 enhances dopaminergic differentiation via the Akt/GSK-3β/β-catenin pathway</article-title><source>Neurobiology of Aging</source><volume>56</volume><fpage>7</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.04.001</pub-id><pub-id pub-id-type="pmid">28478325</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szegő</surname><given-names>É.M</given-names></name><name><surname>Dominguez-Meijide</surname><given-names>A</given-names></name><name><surname>Gerhardt</surname><given-names>E</given-names></name><name><surname>König</surname><given-names>A</given-names></name><name><surname>Koss</surname><given-names>DJ</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Pinho</surname><given-names>R</given-names></name><name><surname>Fahlbusch</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Santos</surname><given-names>P</given-names></name><name><surname>Villar-Piqué</surname><given-names>A</given-names></name><name><surname>Thom</surname><given-names>T</given-names></name><name><surname>Rizzoli</surname><given-names>S</given-names></name><name><surname>Schmitz</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zerr</surname><given-names>I</given-names></name><name><surname>Attems</surname><given-names>J</given-names></name><name><surname>Jahn</surname><given-names>O</given-names></name><name><surname>Outeiro</surname><given-names>TF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in synucleinopathies</article-title><source>Cell Reports</source><volume>28</volume><fpage>65</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.06.009</pub-id><pub-id pub-id-type="pmid">31269451</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szegő</surname><given-names>ÉM</given-names></name><name><surname>Boß</surname><given-names>F</given-names></name><name><surname>Komnig</surname><given-names>D</given-names></name><name><surname>Gärtner</surname><given-names>C</given-names></name><name><surname>Höfs</surname><given-names>L</given-names></name><name><surname>Shaykhalishahi</surname><given-names>H</given-names></name><name><surname>Wördehoff</surname><given-names>MM</given-names></name><name><surname>Saridaki</surname><given-names>T</given-names></name><name><surname>Schulz</surname><given-names>JB</given-names></name><name><surname>Hoyer</surname><given-names>W</given-names></name><name><surname>Falkenburger</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A β-wrapin targeting the N-terminus of α-synuclein monomers reduces fibril-induced aggregation in neurons</article-title><source>Frontiers in Neuroscience</source><volume>15</volume><elocation-id>751</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2021.696440</pub-id><pub-id pub-id-type="pmid">34326719</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szegö</surname><given-names>EM</given-names></name><name><surname>Van den Haute</surname><given-names>C</given-names></name><name><surname>Höfs</surname><given-names>L</given-names></name><name><surname>Baekelandt</surname><given-names>V</given-names></name><name><surname>Van der Perren</surname><given-names>A</given-names></name><name><surname>Falkenburger</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Rab7 reduces α-synuclein toxicity in rats and primary neurons</article-title><source>Experimental Neurology</source><volume>347</volume><elocation-id>113900</elocation-id><pub-id pub-id-type="doi">10.1016/j.expneurol.2021.113900</pub-id><pub-id pub-id-type="pmid">34695425</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voet</surname><given-names>S</given-names></name><name><surname>Srinivasan</surname><given-names>S</given-names></name><name><surname>Lamkanfi</surname><given-names>M</given-names></name><name><surname>van Loo</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inflammasomes in neuroinflammatory and neurodegenerative diseases</article-title><source>EMBO Molecular Medicine</source><volume>11</volume><elocation-id>10248</elocation-id><pub-id pub-id-type="doi">10.15252/emmm.201810248</pub-id><pub-id pub-id-type="pmid">31015277</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Tian</surname><given-names>M</given-names></name><name><surname>Xiao</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Shereen</surname><given-names>MA</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Pan</surname><given-names>P</given-names></name><name><surname>Wan</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection</article-title><source>PLOS Pathog</source><volume>16</volume><elocation-id>8335</elocation-id><pub-id pub-id-type="doi">10.1371/JOURNAL.PPAT.1008335</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>Khawaja</surname><given-names>RR</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Kodama</surname><given-names>L</given-names></name><name><surname>Chin</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Le</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Condello</surname><given-names>C</given-names></name><name><surname>Grinberg</surname><given-names>LT</given-names></name><name><surname>Seeley</surname><given-names>WW</given-names></name><name><surname>Miller</surname><given-names>BL</given-names></name><name><surname>Mok</surname><given-names>SA</given-names></name><name><surname>Gestwicki</surname><given-names>JE</given-names></name><name><surname>Cuervo</surname><given-names>AM</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Gan</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>1969</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-29552-6</pub-id><pub-id pub-id-type="pmid">35413950</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname><given-names>JD</given-names></name><name><surname>Irizarry-Caro</surname><given-names>RA</given-names></name><name><surname>Bennion</surname><given-names>BG</given-names></name><name><surname>Ai</surname><given-names>TL</given-names></name><name><surname>Smith</surname><given-names>AM</given-names></name><name><surname>Miner</surname><given-names>CA</given-names></name><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Gonugunta</surname><given-names>VK</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Platt</surname><given-names>DJ</given-names></name><name><surname>Yan</surname><given-names>N</given-names></name><name><surname>Miner</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>STING-associated vasculopathy develops independently of IRF3 in mice</article-title><source>The Journal of Experimental Medicine</source><volume>214</volume><fpage>3279</fpage><lpage>3292</lpage><pub-id pub-id-type="doi">10.1084/jem.20171351</pub-id><pub-id pub-id-type="pmid">28951494</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>AP</given-names></name><name><surname>Khoury-Hanold</surname><given-names>W</given-names></name><name><surname>Staron</surname><given-names>M</given-names></name><name><surname>Tal</surname><given-names>MC</given-names></name><name><surname>Pineda</surname><given-names>CM</given-names></name><name><surname>Lang</surname><given-names>SM</given-names></name><name><surname>Bestwick</surname><given-names>M</given-names></name><name><surname>Duguay</surname><given-names>BA</given-names></name><name><surname>Raimundo</surname><given-names>N</given-names></name><name><surname>MacDuff</surname><given-names>DA</given-names></name><name><surname>Kaech</surname><given-names>SM</given-names></name><name><surname>Smiley</surname><given-names>JR</given-names></name><name><surname>Means</surname><given-names>RE</given-names></name><name><surname>Iwasaki</surname><given-names>A</given-names></name><name><surname>Shadel</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mitochondrial DNA stress primes the antiviral innate immune response</article-title><source>Nature</source><volume>520</volume><fpage>553</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1038/nature14156</pub-id><pub-id pub-id-type="pmid">25642965</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>SA</given-names></name><name><surname>Boddeke</surname><given-names>H</given-names></name><name><surname>Kettenmann</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Microglia in physiology and disease</article-title><source>Annual Review of Physiology</source><volume>79</volume><fpage>619</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-022516-034406</pub-id><pub-id pub-id-type="pmid">27959620</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>YJ</given-names></name><name><surname>Dobbs</surname><given-names>N</given-names></name><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Liou</surname><given-names>J</given-names></name><name><surname>Miner</surname><given-names>JJ</given-names></name><name><surname>Yan</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death</article-title><source>The Journal of Experimental Medicine</source><volume>216</volume><fpage>867</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1084/jem.20182192</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Shan</surname><given-names>B</given-names></name><name><surname>Geng</surname><given-names>J</given-names></name><name><surname>Dziedzic</surname><given-names>SA</given-names></name><name><surname>Amin</surname><given-names>P</given-names></name><name><surname>Mifflin</surname><given-names>L</given-names></name><name><surname>Naito</surname><given-names>MG</given-names></name><name><surname>Najafov</surname><given-names>A</given-names></name><name><surname>Xing</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Manuel</surname><given-names>VJ</given-names></name><name><surname>Tan</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>ZJ</given-names></name><name><surname>Lee</surname><given-names>VMY</given-names></name><name><surname>Wagner</surname><given-names>G</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Modulating TRADD to restore cellular homeostasis and inhibit apoptosis</article-title><source>Nature</source><volume>587</volume><fpage>133</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2757-z</pub-id><pub-id pub-id-type="pmid">32968279</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>CH</given-names></name><name><surname>Davidson</surname><given-names>S</given-names></name><name><surname>Harapas</surname><given-names>CR</given-names></name><name><surname>Hilton</surname><given-names>JB</given-names></name><name><surname>Mlodzianoski</surname><given-names>MJ</given-names></name><name><surname>Laohamonthonkul</surname><given-names>P</given-names></name><name><surname>Louis</surname><given-names>C</given-names></name><name><surname>Low</surname><given-names>RRJ</given-names></name><name><surname>Moecking</surname><given-names>J</given-names></name><name><surname>De Nardo</surname><given-names>D</given-names></name><name><surname>Balka</surname><given-names>KR</given-names></name><name><surname>Calleja</surname><given-names>DJ</given-names></name><name><surname>Moghaddas</surname><given-names>F</given-names></name><name><surname>Ni</surname><given-names>E</given-names></name><name><surname>McLean</surname><given-names>CA</given-names></name><name><surname>Samson</surname><given-names>AL</given-names></name><name><surname>Tyebji</surname><given-names>S</given-names></name><name><surname>Tonkin</surname><given-names>CJ</given-names></name><name><surname>Bye</surname><given-names>CR</given-names></name><name><surname>Turner</surname><given-names>BJ</given-names></name><name><surname>Pepin</surname><given-names>G</given-names></name><name><surname>Gantier</surname><given-names>MP</given-names></name><name><surname>Rogers</surname><given-names>KL</given-names></name><name><surname>McArthur</surname><given-names>K</given-names></name><name><surname>Crouch</surname><given-names>PJ</given-names></name><name><surname>Masters</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tdp-43 triggers mitochondrial DNA release via MPTP to activate cgas/sting in ALS</article-title><source>Cell</source><volume>183</volume><fpage>636</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.09.020</pub-id><pub-id pub-id-type="pmid">33031745</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yum</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Tbk1 recruitment to sting activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2100225118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2100225118</pub-id><pub-id pub-id-type="pmid">33785602</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">STING ki (STING <break/>N153S knock-in mice)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib45">Luksch et al., 2019</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">C57BL/6 N background, <break/>not the same mouse line <break/>as <xref ref-type="bibr" rid="bib78">Warner et al., 2017</xref></td></tr><tr><td align="left" valign="bottom">Strain (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Ifnar1<sup>-/-</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib67">Siedel et al., 2020</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">backcrossed 20 times to <break/>C57BL/6</td></tr><tr><td align="left" valign="bottom">Strain (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Casp1<sup>-/-</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib62">Reinke et al., 2020</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">C57BL/6 background</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Iba1, rabbit polyclonal</td><td align="left" valign="bottom">Fujifilm Wako Chemicals</td><td align="left" valign="bottom">Cat# 019–19741</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFAP, chicken polyclonal</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab4674</td><td align="char" char="." valign="bottom">1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- NFκB p65 (D14E12), rabbit polyclonal</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 8242</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- Tubulin βIII, rabbit polyclonal</td><td align="left" valign="bottom">Covance</td><td align="left" valign="bottom">Cat# PRB-435P</td><td align="char" char="." valign="bottom">1:5000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho-a-synuclein, rabbit monoclonal</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab51253</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-a-synuclein, mouse monoclonal</td><td align="left" valign="bottom">BD Bioscience</td><td align="left" valign="bottom">Cat# 610787</td><td align="char" char="." valign="bottom">1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- TH, sheep, polyclonal</td><td align="left" valign="bottom">Pel-Freeze</td><td align="left" valign="bottom">Cat# P40101</td><td align="char" char="." valign="bottom">1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-synapsin, chicken monoclonal</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat# 160002</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-homer, rabbit monoclonal</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat# 106006</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ASC, rabbit monoclonal</td><td align="left" valign="bottom">Adipogen</td><td align="left" valign="bottom">Cat# AG-25B-0006-C100</td><td align="char" char="." valign="bottom">1:700</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-IL1b, rabbit monoclonal</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 2022</td><td align="char" char="." valign="bottom">1:300</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- NLRP3, mouse monoclonal</td><td align="left" valign="bottom">Adipogen</td><td align="left" valign="bottom">Cat# AG-20B-00060006</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- NeuN, chicken polyclonal</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat# 266006</td><td align="char" char="." valign="bottom">1:1500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- HDAC1, mouse, monoclonal</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# MA5-1807</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- IRF3, rabbit polyclonal</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">Cat# sc-9082</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- GAPDH, mouse, monoclonal</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">Cat# MAB374</td><td align="char" char="." valign="bottom">1:5000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">HRP conjugated donkey anti-mouse polyclonal</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 715-035-150</td><td align="char" char="." valign="bottom">1:5000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">HRP conjugated donkey anti-rabbit polyclonal</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 711-035-152</td><td align="char" char="." valign="bottom">1:5000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa 555 conjugated donkey anti-rabbit polyclonal</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# A31572</td><td align="char" char="." valign="bottom">1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa 647 conjugated donkey anti-chicken polyclonal</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat# 703-605-155</td><td align="char" char="." valign="bottom">1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa 488 conjugated donkey anti-sheep polyclonal</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# A11015</td><td align="char" char="." valign="bottom">1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa 488 conjugated donkey anti-rabbit polyclonal</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# A21206</td><td align="char" char="." valign="bottom">1:2000</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Ifi44 fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><italic>AACTGACTGCTC<break/>GCAATAATGT</italic></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Ifi44 rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><italic>GTAACACAGCA<break/>ATGCCTCTTGT</italic></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mx1 fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">AACCCTGCTACCTTTCAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mx1 rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">AAGCATCGTTT<break/>TCTCTATTTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Sting1 fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">CTGCTGACATAT<break/>ACCTCAGTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Sting1 rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GAGCATGTTGT<break/>TATGTAGCTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Cxcl10 fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">CCAAGTGCTGC<break/>CGTCATTTTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Cxcl10 rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GGCTCGCAGG<break/>GATGATTTCAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Tnfa fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">CCTGTAGCCC<break/>ACGTCGTAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Tnfa rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GGGAGTAGACA<break/>AGGTACAACCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Casp1 fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GCTGCCTGCCC<break/>AGAGCACAAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Casp1 rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">CTCTTCAGAGTCTCTTACTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Il1b fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GAAATGCCACC<break/>TTTTGACAGTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Il1b rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">TGGATGCTCTCA<break/>TCAGGACAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Hprt1 fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">TCAGTCAACGGG<break/>GGACATAAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Hprt1 rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GGGGCTGTACT<break/>GCTTAACCAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Rpl13 fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">AGCCTACCAGAA<break/>AGTTTGCTTAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Rpl13 rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GCTTCTTCTTCC<break/>GATAGTGCATC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Eef2 fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">CCGACTCCC<break/>TTGTGTGCAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Eef2 rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">AGTTCAGGTCG<break/>TTCTCAGAGAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Ym1 fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">CATTCAGTCAG<break/>TTATCAGATTCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Ym1 rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">AGTGAGTAGCAGCCTTGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Il4 fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">AGATGGATGTGCC<break/>AAACGTCCTCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Il4 rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">AATATGCGAAGCA<break/>CCTTGGAAGCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Nos2 fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">CTGCTGGTGGTGAC<break/>AAGCACATTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Nos2 rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">ATGTCATGAGCAAA<break/>GGCGCAGAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Retnl1 fw primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">TGGAGAATAAGGTCAAGGAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Retnlb rev primer</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GTCAACGAGTAAGCACAGG</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Pierce Micro BCA Protein-Assay-Kit</td><td align="left" valign="bottom">Thermo Fisher Scientific Inc</td><td align="left" valign="bottom">Cat# 23235</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">WesternBright Chemilumineszenz <break/>Substrat Sirius</td><td align="left" valign="bottom">Biozym Scientific GmbH</td><td align="left" valign="bottom">Cat# 541019</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">M-MLV Reverse Transriptase Kit</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# M1701</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SV Total RNA Isolation System</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# Z3101</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">GoTaq qPCR Master Mix</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# A6002</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">PhosSTOP phosphatase inhibitor</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# 4906845001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Precision Plus Protein WesternC Protein Standards</td><td align="left" valign="bottom">BioRad</td><td align="left" valign="bottom">Cat# 1610376</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">RNasin Ribonuclease Inhibitor</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# N2511</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Deoxynucleotide Triphosphates (dNTPs)</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# U1205</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">M-MLV 5 x Reaction Buffer</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# M1701</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Fluoromount-G</td><td align="left" valign="bottom">Southern Biotech</td><td align="left" valign="bottom">Cat# 0100–01</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">NucSpot Live 650 Nuclear Stain</td><td align="left" valign="bottom">Biotium</td><td align="left" valign="bottom">Cat# 40082</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Thioflavin S</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# T1892</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Mitosox</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# M36008</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Di(Acetoxymethyl Ester) <break/>(6-Carboxy-2',7'-<break/>Dichlorodihydrofluorescein <break/>Diacetate) (DCFH-DA)</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# C2938</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism 5. 01 and 9.0.0</td><td align="left" valign="bottom">GraphPad Software</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ Fiji</td><td align="left" valign="bottom">Wayne Rasband (NIH)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">QuantStudio5 qPCR Data <break/>Analysis Software</td><td align="left" valign="bottom">Thermo Fisher Scientific Inc</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">QuantStudio 5 Real-Time <break/>PCR System</td><td align="left" valign="bottom">Thermo Fisher Scientific Inc</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Zeiss Axio Observer Z1</td><td align="left" valign="bottom">Carl Zeiss</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Zeiss Spinning Disc</td><td align="left" valign="bottom">Carl Zeiss</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Infinite 200 M Multimode-<break/>Plate-Reader</td><td align="left" valign="bottom">Tecan Group</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81943.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Keqiang</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/034t30j35</institution-id><institution>Chinese Academy of Sciences</institution></institution-wrap><country>China</country></aff></contrib></contrib-group></front-stub><body><p>STING has recently been implicated in the pathogenesis of neurodegenerative diseases. In the current work, the authors analysed a mouse model that expresses the constitutively active STING variant N153S and demonstrated that activation of the STING pathway via downstream signalling by type I interferons (Ifnar1-/-) or inflammasome activation (Casp1-/-) is sufficient to induce degeneration of dopaminergic neurons. Moreover, STING activation is sufficient to induce α-synuclein pathology in Parkinson's disease. This finding is of interest to the broad readership of <italic>eLife</italic>.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81943.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ye</surname><given-names>Keqiang</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/034t30j35</institution-id><institution>Chinese Academy of Sciences</institution></institution-wrap><country>China</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>[Editors' note: this paper was reviewed by <ext-link ext-link-type="uri" xlink:href="https://www.reviewcommons.org/">Review Commons</ext-link>.]</p><p>Thank you for submitting your article &quot;Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers at Review Commons, and the evaluation at <italic>eLife</italic> has been overseen by a Reviewing Editor and Mone Zaidi as the Senior Editor.</p><p>The revised manuscript has addressed most of the raised concerns in the previous review. Though additional data substantially strengthen the manuscript, two of the referees still remain concerned with some of the data, and they both raised some further concerns.</p><p>For instance, review #2 noted some issues with the new data in Figure 6F-I. &quot;The authors present ASC staining to quantify ASC puncta within microglia and astroglia from striatal sections. Given Iba1+ cells have more total ASC is the increase ni ASC puncta just dut to higher overall levels i.e. if normalised for expression of ASC are there more puncta? Also an explanation for why Casp1 KO have less ASC and ASC puncta is required. Caspase1 is downstream of ASC puncta formation so why is there less ASC and ASC puncta in these KO cells?&quot;. Reviewer #2 felt that their hypothesis is largely confirmed in this revision, and support publication. But before that they should perform MAP2 staining and add some description regarding unexpected findings in Discussion. But s/he complained that &quot;However, some points, which are within my main claims in previous submission, are not yet completely resolved. In Figure 5, pSTAT-positive cells are neurons (this is consistent with their assumption), and NF-κB positive cells also seem non-astrocyte and non-microglia. It is a little bit strange that they did not use the neuronal marker MAP2 for this analysis. They should do this, because brain is a complex tissue, and it is usually unacceptable not to dissect the pathology to cell types in a standard- or high-level journal.&quot;</p><p>If you feel that you could address these concerns, we would expect your resubmission in the near future!</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81943.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>1) “The authors could consider qualifying the observations as preliminary as no mechanistic data or longer-term pathophysiology is investigated. Indeed, the latter is well beyond the current scope and may require generation of cell-type specific STING ki mice.”</p></disp-quote><p>Thank you for the comment. We have qualified our observations as preliminary (line 662). Indeed, generating cell-type specific STING ki mice is part of our future plans.</p><disp-quote content-type="editor-comment"><p>2) The authors consistently write &quot;NF-κB/inflammasomes&quot; – these two pathways (although related) are quite distinct and should not be lumped together in such a way.</p></disp-quote><p>Thank you for this important note, we now corrected the text (for example see section headings in the Results section, lines 338 and 415).</p><disp-quote content-type="editor-comment"><p>3) Line 79: &quot;NRLP3&quot; should be corrected to NLRP3. Line 210: age of &quot;adult mice&quot; in weeks should be state in the text and figure legend.</p></disp-quote><p>Thank you, corrected.</p><disp-quote content-type="editor-comment"><p>4) Line 262: In Figure 3B and D the images look very different and there is no indication of what a positive inclusion is? This should be indicated on the image.</p></disp-quote><p>Thank you for the suggestion. We replaced the corresponding panels with new images, where we show the nuclei with blue, and the Thioflavin S staining with magenta pseudo-color (current Figure 3E). We marked the outline of Thioflavin S positive cells with yellow. An inset showing the magnification of some neurons with inclusions is also presented.</p><disp-quote content-type="editor-comment"><p>5) Line 280: The data of Ifi44 should also be mentioned in the text.</p></disp-quote><p>Thank you. We performed new experiments to show the gene expression changes in the striatum and in the substantia nigra, therefore majority of the gene expression data from the cortex has been moved to the supplementary material (supplemental Figures 3 and 5), and is not discussed in detailed in the current manuscript.</p><disp-quote content-type="editor-comment"><p>6) Line 290: Figure 4, Examining IL-1B and Caspase-1 transcripts is not a readout of inflammasome activation. pro-IL1B is upregulated in response to NFkB activity. Inflammasome activation is commonly examined in other methods e.g. via ASC puncta formation (imaging based), active IL-1B secretion (ELISA), Caspase-1 and IL-1B cleavage via western blot</p></disp-quote><p>Thank you for this suggestion, we performed new experiments and added the data as Figure 6.</p><p>1) We performed Western blot analysis to detect IL-1β cleavage and NLRP3 proteins from the striatum (Figure 6C-E). 2) We quantified the number of ASC puncta within microglia and astroglia from striatal sections (Figure 6F-I). 3). 3) We also measured the protein levels of several additional immune mediators in the striatum of STING ki and KO animals (supplemental Figure 6, summary heatmap is on Figure 7A).</p><disp-quote content-type="editor-comment"><p>7) Line 310: The NF-κB subunit examined should be stated (p65?). Furthermore, IRF3 translocation might be a better readout for STING activation.</p></disp-quote><p>We indeed detected the p65 subunit of NF-κB (antibody is listed in the supplemental Table), and now it is also indicated in the text (line 366).</p><p>We also performed subcellular fractionation and quantified IRF3 in the nuclear and cytoplasmic fractions. The data is now added on Figure 6A, B.</p><disp-quote content-type="editor-comment"><p>8) Discussion: Given the findings here suggest a strong role for NF-κB, a short discussion of IFN vs non-IFN responses from STING should be included. There have been a number of seminal papers demonstrating the importance of non-IFN STING responses of late as well as much evidence from SAVI mice to suggest some non-IFN driven pathologies.</p></disp-quote><p>Thank you for the suggestion. The data on inflammasomes were given a separate section in the results (from line 395). In the discussion, from line 535 we discuss the IFN dependent response and from line 548 we discuss the non-IFN driven pathways.</p><disp-quote content-type="editor-comment"><p>9) Discussion: Is there any evidence from the human SAVI patients of neuroinflammation etc. This should be mentioned either way in the discussion.</p></disp-quote><p>Thank you for this comment. The manifestation of neurological symptoms is not a core feature of the human SAVI disease. Some patients suffer from various neurological symptoms e.g. calcification of basal ganglia, spastic diplegia and episodes of seizure (Fremond et al., 2021).</p><p>We inserted a short text in discussion (lines 532-534).</p><disp-quote content-type="editor-comment"><p>10) Discussion: There is a large body of work demonstrating STING-induced cell death in numerous cell types. Despite this it is not mentioned nor discussed but should be. It could represent how dopaminergic neurons are lost in the STING ki mice.</p></disp-quote><p>Thank you for pointing out the gap in our discussion. We added additional text in lines 604-618.</p><disp-quote content-type="editor-comment"><p>11) The resolution/quality of some of the imaging is not great but this may be due to PDF compression</p><p>Reviewer #2:</p><p>1) The authors base their conclusions (line 215-216) on the neuroinflammatory status of their mice strongly on an assessment of the Iba1 and GFAP-positive area fraction. Increase of Iba1 and GFAP areas does not necessarily correlate with an increased cytokine production and release by the cells. Therefore, in addition the measurement of cytokine mRNAs it would be necessary to measure cytokines also on protein level (see also #4 and #5).</p></disp-quote><p>Thank you for this suggestion, we measured the protein levels of several immune mediators with LEGENDplex assay from the striatum, and the new data are included as Figure 7A and supplemental Figure 6.</p><disp-quote content-type="editor-comment"><p>2) In the same context: Is the increase of Iba1 and GFAP- covered area due to increased proliferation of microglia and astrocytes or due to increased expression of these markers in activated glia? How is the number of Iba1/GFAP-positive cells affected?</p></disp-quote><p>We quantified the number of glia cells in the striatum and in the substantia nigra of adult STING WT and STING ki mice, and, parallel with higher immunoreactivity for the corresponding markers, we detected increased number of cells as well. The quantifications are now included in supplemental Figure 1.</p><disp-quote content-type="editor-comment"><p>3) Nowadays we know that microglia and astrocytes can exist in a variety of activated states which can be either beneficial or detrimental. An analysis of disease-associated microglial markers (Keren-Shaul et al. 2017) would give a good picture of the state microglia are in.</p></disp-quote><p>Thank you for the suggestion. In addition to the panel of immune modulators at the protein level (supplemental Figure 6), we performed qPCR analysis of additional “M1” marker (Nos2) and additional “M2” markers (Il4, Fizz2, Ym1) (Gong et al., 2019). The data is included in Figure 7A and shown in supplemental figure 6. The findings are described from line 431.</p><disp-quote content-type="editor-comment"><p>4) It also would be of interest to determine which cell type is responsible for the observed neurodegeneration. Which cytokines are released by microglia or astrocytes upon STING activation? Even in vitro experiments would help here to get a more profound understanding.</p></disp-quote><p>We agree with the suggestion, however, the further in vitro experiments are beyond the scopes of this study and will be the basis of a future project.</p><disp-quote content-type="editor-comment"><p>5) In line 273 the authors describe that STING is known to activate NFkB and the inflammasome. As proof that this is also occurring in their mouse, they perform qPCR analysis of whole brain IL-1b, TNF-a and Casp1 expression. While this analysis indicates that there is indeed an increased mRNA production of proinflammatory cytokines in the brains of STING ki mice, it does not give any indication whether the inflammasome is active or not. The inflammasome is a protein complex largely regulated on protein level. Meaning an assessment of the cleavage of Caspase 1 on protein level or the presence of cleaved IL-1b in comparison to uncleaved Pro-IL-1b by Western Blot as well as a staining for the number of inflammasomes would be required to draw these conclusions.</p></disp-quote><p>Thank you for the suggestion. We performed additional experiments: (1) Western blot to detect pro-IL1b and IL1b and NLRP3 proteins from the striatum (Figure 6C-E), and (2) we quantified the number of ASC puncta within microglia and astroglia from striatal sections (Figure 6F-I).</p><disp-quote content-type="editor-comment"><p>6) To conclude that NFkb/inflammasome pathway is the most active/crucial in astrocytes (line 354) a staining for ASC inflammasomes would be of importance, especially as astrocytes normally do not express NLRP3.</p></disp-quote><p>Thank you for this comment. We stained brain sections for ASC specks and for microglia (Iba1) and astroglia (GFAP) markers (Figure 6F-I). Although amount of ASC specks in astroglia was lower than in microglia, we found still a substantial amount of ASC specks in astroglia in the brains of STING ki animals.</p><disp-quote content-type="editor-comment"><p>7) As already shown for ALS (Yu et al., 2020) and Parkin KO (Sliter et al. 2018), the authors want to further assess the relevance of the STING pathway to PD (line 27-28). Therefore, an in-depth analysis of key PD hallmarks beyond phosphorylated a-synuclein, lossthe other was parkin/PINK related (so TDP deleted) of TH-stained neurons and dopamine reduction is needed. In the discussion the authors hypothesize that autophagy (line 467) may be linked to the observed phenotype. Therefore, assessment of autophagy/mitophagy as well as mitochondrial dysfunction and mtDNA should be analysed. In the same line of thought it would be important to know if and how the observed dopamine reduction effects mouse behaviour, thus mice should be subjected to the Rotarod or pole or beam walk test.</p></disp-quote><p>Thank you for these suggestions. In the work by Yu et al. and Sliter et al., the STING pathway was shown to mediate neurodegeneration resulting from TDP-43 pathology and mitochondrial damage. Our work is complementary by investigating the effects of constitutive activation of STING. We have therefore focused on the signaling pathways downstream of STING. As mentioned above, the most important next step will be to separate the contributions of neuronal and glial cells by generating cell type specific STING activation. Of course, it will be interesting to see at a later time point whether STING activation feeds back. We also speculate that STING activation may also cause TDP-43 pathology. Yet, this will be part of a future study. To acknowledge that the pathology is not specific to α-synuclein, we added a short statement from line 634.</p><p>With respect to the comprehensive analysis of the PD phenotype, our work includes the classical parameters of TH neuron number, TH fiber density, dopamine concentration and synuclein pathology. With respect to mouse behavior, we note that the STING ki mice have severe inflammation in the lung, kidney and other (peripheral) organs, reduced body weight and reduced lifespan (Luksch et al., 2019; Motwani et al., 2019; Siedel et al., 2020). Motor deficits cannot be attributed to dopamine neuron degeneration and for this reason were not included (stated in the Discussion, lines 624-625). In order to expand the description of the PD phenotype we now included measurements of cytosolic reactive oxygen species, mitochondrial oxygen species and nitric oxide, which result from inflammation and are known to affect dopaminergic neurons (new Figure 8).</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>1) The method for quantification of TH-positive cells is not sufficient. They just described how they stained every fifth sections but did not mention how they count. This is a critical point and they should carefully provide information more than just referring their previous paper.</p></disp-quote><p>Counting of dopaminergic neurons and quantification of fibers was described in a dedicated section of the methods. This section has now been expanded (from line 154).</p><disp-quote content-type="editor-comment"><p>2) It is not persuasive that they did not investigate local inflammation in SN. They presented increased microglia and astrocytes in the striatum but not analyzed these cells in SN.</p></disp-quote><p>Indeed, we measured neuroinflammation in the substantia nigra as well, however, although increased in STING ki mice, it was less pronounced than neuroinflammation in the striatum. We now include the quantification of area fraction as well as cell number counting of microglia and astroglia in the substantia nigra of STING WT and STING ki animals (supplemental Figure 1), and also the expression of inflammatory mediators in Figure 4.</p><disp-quote content-type="editor-comment"><p>3) In Figure 3, they analyzed α-synuclein phosphorylation and β-sheet structure in the striatum. This is funny from the aspect of Parkinson's disease, which dominantly affects SN. They should perform similar experiments with SN samples. In a different aspect, the aggregates detected by Thio S may not be α-synuclein and could be tau, TDP43 or other substances. Phospho-synuclein of course does not mean aggregation, so they can consider electron microscopy.</p></disp-quote><p>We agree with the reviewer. To complement our data, we therefore performed solubility assay both from the striatum and from the substantia nigra to quantify the ratio of α-synuclein in the Triton X-100 soluble and insoluble fractions (Figure 3C, D) as previously (Szego et al., 2022; Szegő et al., 2019). Additionally, we quantified phosphorylated α-synuclein from the substantia <italic>nigra a</italic>s well (Figure 3A,B).</p><p>We also agree with the reviewer that the presence of Thioflavin S-positive inclusions may also contain other, β-sheet forming proteins and noted this from line 634.</p><disp-quote content-type="editor-comment"><p>4) Figure 5, pSTAT3 increased in Iba1-negative cells, which seem neurons from the size of nuclei. First, the authors should investigate the identity of pSTAT3-positive cells with GFAP and MAP2. If pSTAT3 is actually increased in neurons, what does it mean in the pathology? For instance, in viral infection, STAT3 activation triggers suicide of neurons to prevent further proliferation of viral particles in neurons. Is it homologous or other function?</p></disp-quote><p>Thank you for this suggestion. The brain sections were stained for Iba1 and GFAP. pSTAT3 nuclear staining indeed increased in non-glia cells, based on the morphology, we think in neurons. However, detailed characterization of the signal is out of the scopes of this (preliminary) study.</p><disp-quote content-type="editor-comment"><p>5) In Figure 6 and overall, cell types in which the activation of three signaling pathways, were mixed up and hard to understand the actual situation in the brain.</p></disp-quote><p>In our model, STING is activated in all cells. Consequently, we cannot determine the origin of immune mediators found elevated in the STING ki mice. This will require cell type specific STING activation. In order to react to the reviewer’s comment and be clearer, we have added more details about the brain region and age of mice used for each analysis also in the figures.</p><disp-quote content-type="editor-comment"><p>6) In the method section, the original paper for generation of heterozygous STING N153S KI mice should be Warner et al., JEM 2017.</p></disp-quote><p>We used a STING N153S ki mouse strain that was independently generated in the Technical University Dresden (Luksch et al., 2019).</p><disp-quote content-type="editor-comment"><p>7) NF-κB stains seem located in cytoplasm in Figure 5B.</p></disp-quote><p>We agree: especially in the young STING ki mice, cytoplasmic NF-κB staining is increased compared to STING WT mice. To quantify nuclear translocation, however, we counted the number of those cells where NF-κB signal was overlapping with the nuclear Hoechst staining.</p><disp-quote content-type="editor-comment"><p>8) In Figure 4 and 6, why the authors evaluate gene expressions in frontal cortex instead of SN or striatum.</p></disp-quote><p>As noted in several comments, we show here that the STING-induced pathology involves dopaminergic neurons, but believe that it is not specific for the dopaminergic system given that STING-ki is ubiquitously expressed. For practical reasons, we have used cortical samples for the expression analysis. For consistency, we now performed additional qPCR measurement from the striatum and from the substantia nigra and included them as new Figure 4 and supplemental Figure 6N-Q. The previous data from the cortex was moved to the supplemental Figures 3 and 5. Additionally, we measured the levels of several inflammatory modulators from the striatum of STING ki and KO animals (Figure 7A and supplemental figure 6A-M).</p><disp-quote content-type="editor-comment"><p>9) In some groups (Sting-ki;ifnar1-/- in Figure 6C, 6E), the values were separated to two groups, which makes readers to doubt on soundness of their genotyping.</p></disp-quote><p>Our genotyping protocol is highly standardized, and the genotype of the animals were correctly assigned. In <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref> we provide an example of gel images showing the products after PCR reactions for the STING N153S allele (<xref ref-type="fig" rid="sa2fig1">Author response image 1a</xref>), STING WT allele (<xref ref-type="fig" rid="sa2fig1">Author response image 1b</xref>), Ifnara WT allele (<xref ref-type="fig" rid="sa2fig1">Author response image 1c</xref>) and lack of Ifnara allele (<xref ref-type="fig" rid="sa2fig1">Author response image 1d</xref>) of the same animals. We note that a bimodal distribution of phenotypes is often observed in <italic>Ifnar-/-</italic> mice.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Example for correct genotyping of animals used in the experiments.</title><p>(a) PCR product by using primers specifically detecting the N153S variant of STING. (b) PCR product by using primers specifically detecting the WT (mouse) variant of STING. Mice with ID 66, 69, 70 and 71 are STING ki expressing both the mutant Sting1 and the WT Sting1. Mice with ID 67, 68, 72, 73 are STING WT. (c) PCR product by using primers specifically detecting the mouse Ifnar. (d) PCR product by using primers specifically detecting the lack of mouse Ifnar. All mice are Ifnar<sup>-/-</sup>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-sa2-fig1-v2.tif"/></fig><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>The revised manuscript has addressed most of the raised concerns in the previous review. Though additional data substantially strengthen the manuscript, two of the referees still remain concerned with some of the data, and they both raised some further concerns.</p><p>For instance, review #2 noted some issues with the new data in Figure 6F-I. &quot;The authors present ASC staining to quantify ASC puncta within microglia and astroglia from striatal sections. Given Iba1+ cells have more total ASC is the increase ni ASC puncta just dut to higher overall levels i.e. if normalised for expression of ASC are there more puncta?</p></disp-quote><p>In response to this comment, we measured the mean fluorescence intensity in the ASC channel from the same images that we used for ASC puncta analysis. Indeed, the intensity of the ASC signal was higher in Iba1-positive microglia than in GFAP-positive astroglia. This difference was observed in both genotypes, but particularly pronounced in STING ki animals. The data was added as the new supplemental Figure 5J and noted in line 424ff. As hypothesized by the reviewer, the increase in ASC staining intensity correlated strongly with the increase in ASC puncta as in author response image 2.</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81943-sa2-fig2-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>Also an explanation for why Casp1 KO have less ASC and ASC puncta is required. Caspase1 is downstream of ASC puncta formation so why is there less ASC and ASC puncta in these KO cells?&quot;.</p></disp-quote><p>Inflammasomes are multiprotein complexes which are formed and activated upon recognition of pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs). Formation of inflammasomes results in caspase-1 activation followed by IL-1b release. Inflammasome formation in mice requires priming via NF-κB to induce expression of the scaffold protein NLRP3 (Bauernfeind et al. J Immunol 183 (2) 2009; Broz &amp; Dixit. Nature Rev Immunol 16 (7) 2016). This priming is reduced in <italic>Casp1</italic>-/- mice due to the reduction of IL-1b cleavage and release and, hence, less NF-κB activation. In conclusion, inflammasome activation is reduced in caspase-1 deficient mice.</p><p>This background was clarified in line 431ff. of the text.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 felt that their hypothesis is largely confirmed in this revision, and support publication. But before that they should perform MAP2 staining and add some description regarding unexpected findings in Discussion. But s/he complained that &quot;However, some points, which are within my main claims in previous submission, are not yet completely resolved.</p><p>In Figure 5, pSTAT-positive cells are neurons (this is consistent with their assumption), and NF-κB positive cells also seem non-astrocyte and non-microglia. It is a little bit strange that they did not use the neuronal marker MAP2 for this analysis. They should do this, because brain is a complex tissue, and it is usually unacceptable not to dissect the pathology to cell types in a standard- or high-level journal.&quot;</p></disp-quote><p>This is correct. In response to the reviewer, we stained striatal sections for pSTAT3, NeuN as neuronal marker and Iba1 for microglia. Indeed, the majority (app. 85%) of the nuclear pSTAT3 signal colocalized with NeuN. Conversely, almost 70% of striatal neurons were positive for pSTAT3 in STING ki animals. The new data is included as supplemental Figure 4 and added to the results (line 377ff).</p></body></sub-article></article>